Your browser is no longer supported. Please, upgrade your browser.
Settings
IWM iShares Russell 2000 daily Stock Chart
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.59%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month4.26%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter7.00%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.85 Perf Half Y14.06%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year40.84%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range97.46 - 140.32 Perf YTD3.51%
Dividend1.91 P/FCF- EPS past 5Y- ROI- 52W High-0.53% Beta-
Dividend %1.37% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low43.21% ATR1.57
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)60.83 Volatility0.86% 1.06%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.52 Prev Close140.20
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume28.77M Price139.58
Recom- SMA201.94% SMA502.47% SMA20012.79% Volume14,872,195 Change-0.44%
Feb-22-17 02:02PM  Charlie Munger Describes How to Make Money in the Market
08:39AM  Momentum Points to Sector Rotation toward the Russell 2000
07:36AM  US Retail Sales Weakened: Will It Impact Consumer Spending?
07:36AM  How Are Investments Doing in the United States?
Feb-21-17 12:55PM  Rising Oil Price Gives Stock-Index ETFs A Boost
10:52AM  Bulls Push Momentum for Major Equity ETFs
Feb-18-17 12:59PM  Markets To Watch This Week at Forbes
08:00AM  What to expect from the stock market this week
Feb-17-17 05:22PM  Four Sector ETFs That Will Profit In The Months Ahead at Forbes
04:35PM  Stock Market Video Analysis 2/17/17
01:31PM  Stocks Receive a Boost from Strong Earnings at Investopedia
11:00AM  Some Divine Investing Ideas From Apollo Global Management
Feb-16-17 08:04AM  Waves Building Higher in the Russell 2000
04:20AM  Druckenmiller Added Positions in Three ETFs in Q4 at Investopedia
Feb-15-17 04:31PM  Stock Market Video Analysis 2/15/17
02:35PM  January US Services PMI: Have Business Conditions Improved?
02:55AM  A magic bullet is about to push U.S. stocks higher at MarketWatch
Feb-14-17 06:21PM  Stanley Druckenmiller Gains 3 ETF Positions in 4th Quarter
12:22PM  Bull trend confirmed: Charting the S&P 500s break to clear skies territory at MarketWatch
Feb-13-17 05:00PM  Are we in stock nirvana?
04:38PM  Desperate Bears Are Running Out of Arguments
01:40PM  Bulls Still Roar for ETFs for 5 Major Equity Averages
09:34AM  US Consumer Sentiment Impacts Crude Oil and Natural Gas
08:27AM  How one key Trump trade has regained its fizz in one chart at MarketWatch
08:24AM  Corning Could Really Surprise on the Upside at TheStreet
Feb-11-17 11:40AM  Markets To Watch In The Week Ahead at Forbes
08:00AM  What to expect from the stock market this week
Feb-10-17 05:15PM  The Week Ahead: The Charts Won't Lead You Astray Like P/E Ratios at Forbes
05:00PM  Record highs, take profits?
03:10PM  Strong Earnings and Tax Cuts Send Stocks Higher at Investopedia
11:47AM  How Does the Energy Sector Impact the Market?
11:44AM  Stock ETFs Led Higher By Oil, Materials, Small Caps
Feb-09-17 10:36AM  Will the Feds Hawkish Stance Change?
09:35AM  Market Has No Follow-Through, Like a Bad Golf Swing
09:06AM  US Consumer Confidence Improved: What It Means for the Economy
07:21AM  Rev's Forum: Focus on Today's Market Action; Don't Try to Predict Tomorrow
Feb-08-17 03:35PM  Key ADP Report Highlights: 246,000 New Jobs in January
10:56AM  If The Market Gets More Volatile, Long Strangles Could Come In To Play at Insider Monkey
10:53AM  This Highly Bullish Sentiment Is Just Weird
07:00AM  Trader's Daily Notebook: Scalpers Seize the Day
Feb-07-17 04:26PM  A Strong Theme in the Market Now Is That There Are No Strong Themes in the Market Now
12:25PM  Bull trend intact, S&P 500s February breakout attempt underway at MarketWatch
12:08PM  Is Bullish Sentiment Now Low Enough? at Forbes
10:40AM  Why Bill Miller Is Optimistic about Delta Air Lines
Feb-06-17 10:09AM  Are the Bullish Runs for These Major Stock Market Indices Dying?
Feb-04-17 10:59AM  Markets To Watch In The Week Ahead at Forbes
08:00AM  What to expect from the stock market this week
Feb-03-17 05:02PM  Stock Market Video Analysis 2/3/17
05:00PM  Trump rally back on?
04:49PM  The Week Ahead: Trump's 1st Quarter - Pain Or Gain? at Forbes
04:45PM  Stocks Mixed as Political Risk Rises (SPY, DIA) at Investopedia
12:35PM  Jim Grant: Will the Fed Be Dovish or Hawkish in the Coming Year?
11:05AM  How Jim Grant Thinks Trump Presidency Could Affect Markets
09:29AM  Jim Grants View on Market Valuation: Is It Attractive?
Feb-02-17 04:17PM  Why join a prop desk?
07:36AM  What Is Mario Gabellis View on Viacom?
Feb-01-17 11:00AM  Yes, Small-Cap ETFs Work When Rates Rise
07:38AM  Mario Gabelli: Fiscal Stimulus Could Be Important Driver for US
07:00AM  Trader's Daily Notebook: Post-Election Rally in Small-Caps Isn't Over Yet
06:03AM  Charts Say: Go Long the Russell 2000 in February as Small-Caps Set to Shine
Jan-31-17 03:15PM  Trying To Reserve Judgment On A New ETF
12:55PM  Market bears fire shot across the bow, S&P 500 ventures under the breakout point at MarketWatch
11:16AM  Trading Action Has Improved, Here's What I Am Playing
09:08AM  Comparing Keane Groups Net Debt and Leverage with Peers
07:38AM  Bill Gross Says These Factors Have Encouraged Risk
Jan-30-17 05:01PM  Buy the Trump slump?
02:48PM  Investors Fret Political Wrangling Could Complicate Market-Friendly Policies at The Wall Street Journal
01:35PM  US Flash Manufacturing PMI Improved: Is It Bringing Optimism?
10:10AM  US Consumer Sentiment Rose: Is It Increasing Investor Confidence?
10:02AM  The Bull Continues Rampage Through the U.S. Stock Market
07:00AM  Trader's Daily Notebook: No Point Taking Guesses at Whether the Rally Will Fail
Jan-28-17 11:43AM  Markets To Watch In The Week Ahead at Forbes
08:00AM  What to expect from the stock market this week
Jan-27-17 06:35PM  Stocks Rally on Improving Economic Outlook (SPY, DIA) at Investopedia
04:47PM  The Week Ahead: Wait For Signs Of A Trump Bear Market at Forbes
03:51PM  Stock Market Analysis Video 1/27/17
11:05AM  What Does Ray Dalio Think about Populism?
09:19AM  Ray Dalio: The Market Has Discounted the Obvious
07:00AM  Trader's Daily Notebook: What If This Isn't a Bull Trap?
Jan-26-17 09:46AM  Trump Trade: Game On at The Wall Street Journal
08:08AM  Time to Substitute the Russell for the Nasdaq
Jan-25-17 04:17PM  Stock Market Analysis Video 1/25/17
11:37AM  Financial And Industrial Sectors Lead Stock ETFs Higher
11:35AM  What Does Carl Icahn Think about Environmental Protection Agency?
10:10AM  Hey Short-Sellers, Just Don't Drop the 'Match' on the Carpet
10:05AM  What Will Donald Trumps Term Mean for Markets?
08:20AM  Carl Icahn on Trump Inauguration: Future Will Be More Competitive
06:00AM  Rising Debt in Equity Funds Is a Formula for Disaster at Investopedia
Jan-24-17 12:54PM  Bull trend bends (slightly) without cracking, S&P 500 approaches record close at MarketWatch
11:05AM  US CPI Meets Expectations: Will It Drive Market Sentiment?
Jan-23-17 05:27PM  Mr. Wonderfuls Trump ETFs
03:33PM  What Investors Should Watch After Inauguration Day at The Wall Street Journal
10:26AM  5 Stock Indices That Are Now Flashing Overbought Signals
09:07AM  Sanderson Farms Declares Dividend of $0.24 per Share
07:00AM  Trader's Daily Notebook: It Makes Sense to Look for Reasons to Be Bullish
05:26AM  The S&P 500 probably will rise this year, but it might take the scenic route at MarketWatch
Jan-21-17 11:17AM  The Week Ahead: Markets To Watch at Forbes
08:00AM  What to expect from the stock market this week
Jan-20-17 05:49PM  Stocks Move Slightly Lower as Trump Takes Office at Investopedia
05:13PM  The Week Ahead: The Reagan Markets at Forbes
The investment seeks to track the investment results of the Russell 2000 Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
DHR Danaher Corporation daily Stock Chart
DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E27.60 EPS (ttm)3.07 Insider Own0.10% Shs Outstand693.35M Perf Week0.83%
Market Cap58.80B Forward P/E19.80 EPS next Y4.28 Insider Trans-36.44% Shs Float605.54M Perf Month6.00%
Income2.15B PEG2.91 EPS next Q0.84 Inst Own78.20% Short Float0.98% Perf Quarter7.53%
Sales16.88B P/S3.48 EPS this Y24.80% Inst Trans-0.16% Short Ratio2.09 Perf Half Y5.12%
Book/sh33.19 P/B2.55 EPS next Y8.62% ROA5.50% Target Price90.44 Perf Year28.93%
Cash/sh1.39 P/C61.01 EPS next 5Y9.48% ROE10.70% 52W Range65.02 - 85.07 Perf YTD8.94%
Dividend0.50 P/FCF23.22 EPS past 5Y2.10% ROI6.00% 52W High-0.32% Beta1.02
Dividend %0.59% Quick Ratio0.70 Sales past 5Y1.00% Gross Margin55.30% 52W Low30.42% ATR0.91
Employees81000 Current Ratio1.00 Sales Q/Q6.00% Oper. Margin15.20% RSI (14)69.69 Volatility0.91% 1.13%
OptionableYes Debt/Eq0.53 EPS Q/Q42.40% Profit Margin15.10% Rel Volume0.72 Prev Close84.75
ShortableYes LT Debt/Eq0.42 EarningsJan 31 BMO Payout15.70% Avg Volume2.85M Price84.80
Recom1.70 SMA202.12% SMA504.87% SMA2007.86% Volume2,066,548 Change0.06%
Feb-01-17Initiated Credit Suisse Outperform $93
Jan-18-17Initiated Deutsche Bank Buy $88
Dec-13-16Resumed Morgan Stanley Overweight
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Apr-18-16Reiterated Barclays Overweight $99 → $104
Apr-04-16Downgrade Bernstein Outperform → Mkt Perform
Jan-27-16Reiterated RBC Capital Mkts Sector Perform $93 → $87
Dec-08-15Downgrade Goldman Buy → Neutral
Oct-26-15Reiterated Argus Buy $98 → $104
Oct-23-15Reiterated Stifel Buy $98 → $103
Oct-23-15Reiterated RBC Capital Mkts Sector Perform $91 → $92
Oct-23-15Reiterated Barclays Overweight $89 → $94
Oct-01-15Reiterated Stifel Buy $100 → $98
Sep-30-15Initiated Leerink Partners Outperform
Feb-22-17 06:06AM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
06:03AM  DANAHER CORP /DE/ Files SEC form 10-K, Annual Report
Feb-21-17 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
04:15PM  Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board PR Newswire
Feb-16-17 04:15PM  Danaher To Present At Barclays Industrial Select Conference PR Newswire
Feb-09-17 08:15AM  Post Earnings Coverage as Honeywell's Adjusted EPS Surged 14%; Reaffirms FY17 Outlook Accesswire
Feb-08-17 06:01AM  ATS Automation appoints new Chief Executive Officer CNW Group
06:00AM  ATS Reports Third Quarter Fiscal 2017 Results CNW Group
Feb-06-17 01:30PM  Locust Wood Boosts Exposure to These Companies at Insider Monkey
Feb-03-17 09:07AM  What to Expect from Danahers Future Earnings
07:37AM  A Closer Look at Danahers Leverage and Liquidity
Feb-02-17 02:35PM  Pulling Back the Curtain on Danahers 4Q16 Operating Performance
01:05PM  How Did Danahers Operating Segments Fare in 4Q16?
11:34AM  Why Danaher Stock Rose after Its 4Q16 Results
Feb-01-17 05:58AM  Coverage initiated on Danaher by Credit Suisse
Jan-31-17 03:33PM  One of the Hottest Stocks This Year Is Still a Screaming Buy
03:09PM  Edited Transcript of DHR earnings conference call or presentation 31-Jan-17 12:30pm GMT
10:13AM  Danaher (DHR) Q4 Earnings & Revenues Top, Increase Y/Y
07:27AM  Danaher (DHR) Beats on Q4 Earnings & Revenue Estimates
07:14AM  Market Recon: Political Risk Shows Signs of Becoming Ongoing Condition
07:07AM  Q4 2016 Danaher Corp Earnings Release - 06:00 am ET
06:22AM  Danaher tops Street 4Q forecasts
06:00AM  Danaher Reports Fourth Quarter And Full Year 2016 Results PR Newswire
Jan-27-17 09:32AM  Danaher (DHR) Q4 Earnings: What's in Store for the Stock?
Jan-20-17 12:12PM  This Hedge Fund Bought $3 Billion of ABB Ltd Stock: Should You Buy, Too? at Motley Fool
Jan-18-17 09:08AM  What Investors Should Know about Danahers Leverage and Liquidity
07:37AM  A Look at Danahers 4Q16 Margin Estimates
Jan-17-17 06:56PM  Two settle U.S. charges on failing to file stock buys with regulator Reuters
04:36PM  Behind Danahers 4Q16 Revenue Estimates
03:06PM  How Do Analysts Rate Danaher ahead of Its 4Q16 Results?
01:23PM  What Factors Could Drive Danaher Stock in 2017?
Jan-11-17 04:15PM  Danaher Schedules Fourth Quarter 2016 Earnings Conference Call PR Newswire
Jan-10-17 08:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Jan-04-17 04:15PM  Danaher To Present At J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 09:09AM  Danaher May Not Have Much More Growth in Store
09:07AM  Here's Why You Avoid Fortive Now
Dec-30-16 09:30AM  The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna
Dec-27-16 01:22PM  Is Danaher Corporation Stock a Buy for 2017? at Motley Fool
Dec-26-16 07:37AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 26, 2016
Dec-15-16 11:37AM  Danaher Corp. Value Analysis (NYSE:DHR) : December 15, 2016
11:03AM  Danaher Does It at Barrons.com
06:00AM  Danaher Initiates 2017 Outlook PR Newswire
Dec-14-16 07:27AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 14, 2016
Dec-13-16 03:05PM  4 Industrial Stock Winners From Trump's Lower Taxes at Barrons.com
Dec-09-16 05:03PM  Ecolab Declares a Dividend of $0.37 per Share
Dec-08-16 08:39AM  Pantone hopes its color of the year will improve our gloomy mood
07:53AM  Will Danaher (DHR) Gain from Restructuring Initiatives?
Dec-06-16 04:55PM  DANAHER CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
04:15PM  Danaher Announces Quarterly Dividend PR Newswire
Dec-02-16 10:42AM  ETFs with exposure to Danaher Corp. : December 2, 2016
Dec-01-16 08:00AM  Danaher announces leadership appointment PR Newswire
07:38AM  Danaher Corp. breached its 50 day moving average in a Bearish Manner : DHR-US : December 1, 2016
07:32AM  GE Completes Strategic Divestiture of Interbanca Business
Nov-30-16 08:43AM  GE Poised on Strategic Organic Growth with Healthcare Focus
Nov-29-16 08:09AM  3M Company Trails Industry Performance Post 3Q Earnings
08:07AM  What Does Wall Street Expect from Donaldsons Fiscal 1Q17 Earnings?
07:38AM  Crane Fundamentally Strong, '16 View Solid: Time to Buy?
Nov-28-16 05:59PM  Final Trade: P, GDX & more
05:45PM  Is U.S. Bancorp (USB) a Good Stock To Buy? at Insider Monkey
04:41PM  GE to Strategically Expand Healthcare Portfolio at RSNA 2016
08:16AM  United Technologies Shows Promise with in Line Performance
Nov-27-16 09:02PM  Here is What Hedge Funds Think About Danaher Corporation (DHR) at Insider Monkey
Nov-24-16 08:31AM  Crane Hits New 52-Week High on Solid Performance & View
Nov-23-16 06:33AM  Compass Diversified Partially Divests Fox Factory Shares
Nov-22-16 04:58PM  Snap-on: Ratcheting Up Margins and Other Vital Metrics
09:30AM  The Zacks Analyst Blog Highlights: Coca-Cola, Disney, Danaher, Halliburton and Time Warner
07:52AM  GE Collaborates with Prysm to Enhance Digital Platform
Nov-21-16 12:44PM  Top Research Reports for 21st November, 2016
11:12AM  3M: Not Much To Gain From A Trump World at Barrons.com
07:28AM  Ingersoll (IR) Poised for Top-Line Growth, Risks Remain
Nov-17-16 11:09AM  A Closer Look At Tiger Legatus Capitals Top Moves: AMAYA (AYA), Danaher Corporation (DHR) & Others at Insider Monkey
Nov-16-16 10:21AM  Joel Greenblatt's Top 3 New Holdings for the 3rd Quarter
10:10AM  Merrill Lynch Makes 2 Huge New Additions to US 1 Stock List at 24/7 Wall St.
08:12AM  GE Solidifies Presence in Molecular Imaging with DILON Deal
Nov-15-16 06:03PM  [$$] Gap Names Former Kraft Finance Chief as Next CFO at The Wall Street Journal
09:14AM  United Technologies' Arm in Deal with Mexican VivaAerobus
07:34AM  GE Digital Buys ServiceMax to Augment Industrial Internet
Nov-14-16 04:15PM  Danaher To Webcast Investor And Analyst Meeting PR Newswire
11:52AM  3M & Danaher: Do Earnings Even Matter in Trump's Brave New World? at Barrons.com
Nov-10-16 07:37AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events
Nov-04-16 07:20PM  Danaher Completes Acquisition Of Cepheid PR Newswire
Nov-03-16 07:18AM  UTX's Pratt & Whitney Consortium to Power A320ceo Aircraft
Nov-01-16 08:15AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : November 1, 2016
Oct-31-16 04:15PM  Danaher to Present at Baird Industrial Conference PR Newswire
Oct-28-16 08:15AM  Post Earnings Coverage as Danaher Q3 Earnings Shine on Acquisition Accesswire
Oct-25-16 04:13PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obli
02:42PM  ETFs with exposure to Danaher Corp. : October 25, 2016
01:04PM  DANAHER CORP /DE/ Financials
11:05AM  Danaher Marginally Raises Its Fiscal 2016 Guidance on Better YTD Performance
10:56AM  3M (MMM) Marginally Beats Q3 Earnings, Trims 2016 Guidance
10:05AM  With Phenomenex, Danaher Has an Attractive Consumables Asset
08:05AM  Pall, High Growth Regions Take Danahers Sales Higher in 3Q16
Oct-24-16 05:03PM  Danaher Stock Jumps as EPS Grows 22.5% on Margin Expansion
10:00AM  Danaher Corp. :DHR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
Oct-21-16 06:15PM  Cramer: DHR and ITW have less in common than at first gla...
11:09AM  Earnings show signs of life
10:50AM  Honeywell (HON) Beats on Earnings in Q3, Tweaks Guidance
08:16AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : October 21, 2016
Oct-20-16 03:02PM  Edited Transcript of DHR earnings conference call or presentation 20-Oct-16 12:00pm GMT
10:33AM  Danaher (DHR) Q3 Earnings Top Estimates, Revenues Up Y/Y
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company's Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company's Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LOHR WALTER GDirectorFeb 15Option Exercise28.4910,578301,36718,831Feb 16 04:40 PM
SCHWIETERS JOHN TDirectorFeb 15Option Exercise28.4910,578301,36737,784Feb 16 04:47 PM
LOHR WALTER GDirectorFeb 15Sale84.3210,578891,9378,253Feb 16 04:40 PM
SCHWIETERS JOHN TDirectorFeb 15Sale84.2910,578891,62027,206Feb 16 04:47 PM
EHRLICH DONALD JDirectorFeb 14Option Exercise28.4910,578301,36795,378Feb 15 04:40 PM
EHRLICH DONALD JDirectorFeb 14Sale83.9810,578888,34084,800Feb 15 04:40 PM
COMAS DANIEL LEVP & CFOFeb 01Option Exercise19.8965,0001,292,850216,945Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOFeb 01Option Exercise21.48196,3094,217,429329,466Feb 03 04:32 PM
Raskas DanielSVP-Corporate DevelopmentFeb 01Option Exercise28.5534,168975,49660,429Feb 03 04:33 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 01Option Exercise28.5534,168975,49665,015Feb 03 04:33 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 01Sale84.1034,1682,873,52930,847Feb 03 04:33 PM
Raskas DanielSVP-Corporate DevelopmentFeb 01Sale84.0034,1682,870,11226,261Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOFeb 01Sale83.74196,30916,438,916169,282Feb 03 04:32 PM
COMAS DANIEL LEVP & CFOFeb 01Sale83.4965,0005,426,850151,945Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOOct 21Option Exercise28.5536,1251,031,369205,407Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOOct 21Sale79.6836,1252,878,296169,282Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Option Exercise28.5536,1251,031,369205,407Aug 02 06:07 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Sale81.4445,8973,737,980169,282Aug 02 06:07 PM
COMAS DANIEL LEVP & CFOJul 27Option Exercise22.2696,4462,147,333259,270Jul 29 07:56 AM
COMAS DANIEL LEVP & CFOJul 27Sale80.8896,4467,800,332189,270Jul 29 07:56 AM
HEFNER LINDA PDirectorJul 11Option Exercise23.8810,578252,60320,197Jul 12 04:54 PM
Lalor Angela SSVP, Human ResourcesMay 12Sale97.778,392820,46148,110May 13 08:41 AM
SCHWIETERS JOHN TDirectorMay 06Option Exercise31.578,000252,56026,958May 09 05:36 PM
LICO JAMES AExecutive Vice PresidentApr 27Option Exercise37.7540,0001,510,000181,517Apr 29 07:27 AM
LICO JAMES AExecutive Vice PresidentApr 27Sale96.9358,9545,714,495122,563Apr 29 07:27 AM
Raskas DanielSVP-Corporate DevelopmentApr 22Option Exercise37.0724,300900,80141,524Apr 26 05:03 PM
DANIEL WILLIAM KEVPApr 22Option Exercise39.8226,1401,040,895164,785Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Option Exercise37.7589,2803,370,320230,978Apr 26 05:04 PM
COMAS DANIEL LEVP & CFOApr 22Sale95.7189,2808,545,015141,698Apr 26 05:04 PM
DANIEL WILLIAM KEVPApr 22Sale96.0641,1403,952,086123,645Apr 26 05:03 PM
Joyce Thomas Patrick JRPresident and CEOApr 22Sale95.5014,6301,397,165137,246Apr 26 05:04 PM
King WilliamSenior Vice PresidentApr 22Sale96.316,000577,86017,386Apr 26 05:02 PM
Raskas DanielSVP-Corporate DevelopmentApr 22Sale95.9524,3002,331,58517,224Apr 26 05:03 PM
LICO JAMES AExecutive Vice PresidentFeb 29Option Exercise37.2460,0002,234,155186,878Mar 01 05:56 PM
LICO JAMES AExecutive Vice PresidentFeb 29Sale89.2460,0005,354,348141,517Mar 01 05:56 PM
LOHR WALTER GDirectorFeb 26Option Exercise31.578,000252,560461,505Feb 29 05:48 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale89.004,656414,38417,786Feb 29 05:48 PM
LOHR WALTER GDirectorFeb 26Sale89.068,000712,440453,505Feb 29 05:48 PM
WY Weyerhaeuser Co. daily Stock Chart
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E64.18 EPS (ttm)0.53 Insider Own0.10% Shs Outstand748.06M Perf Week1.41%
Market Cap25.25B Forward P/E25.54 EPS next Y1.32 Insider Trans-9.98% Shs Float736.97M Perf Month10.94%
Income393.00M PEG12.84 EPS next Q0.16 Inst Own79.40% Short Float1.77% Perf Quarter8.45%
Sales6.37B P/S3.97 EPS this Y-23.00% Inst Trans0.60% Short Ratio3.11 Perf Half Y10.29%
Book/sh12.26 P/B2.75 EPS next Y32.60% ROA4.80% Target Price34.46 Perf Year45.06%
Cash/sh0.90 P/C37.36 EPS next 5Y5.00% ROE10.60% 52W Range22.18 - 34.10 Perf YTD12.20%
Dividend1.24 P/FCF- EPS past 5Y-1.60% ROI4.80% 52W High-1.00% Beta1.36
Dividend %3.67% Quick Ratio1.00 Sales past 5Y0.50% Gross Margin22.60% 52W Low52.21% ATR0.63
Employees12600 Current Ratio1.30 Sales Q/Q26.10% Oper. Margin13.70% RSI (14)65.24 Volatility1.55% 2.13%
OptionableYes Debt/Eq0.78 EPS Q/Q-43.50% Profit Margin15.80% Rel Volume0.56 Prev Close33.98
ShortableYes LT Debt/Eq0.75 EarningsFeb 03 BMO Payout92.00% Avg Volume4.21M Price33.76
Recom2.10 SMA204.28% SMA507.28% SMA2009.81% Volume2,360,342 Change-0.65%
Jan-09-17Upgrade Raymond James Outperform → Strong Buy
Dec-15-16Downgrade CLSA Outperform → Underperform
Sep-22-16Initiated Goldman Buy $37
Aug-12-16Downgrade Dundee Buy → Neutral
Aug-08-16Downgrade DA Davidson Buy → Neutral $33
Jun-29-16Upgrade DA Davidson Neutral → Buy
May-09-16Downgrade DA Davidson Buy → Neutral $34 → $33
Feb-17-16Reiterated Argus Buy $43 → $28
Jan-19-16Upgrade Dundee Neutral → Buy
Nov-17-15Reiterated RBC Capital Mkts Outperform $37 → $35
Nov-13-15Upgrade Credit Agricole Underperform → Outperform
Sep-15-15Upgrade BofA/Merrill Neutral → Buy
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Feb-22-17 05:45PM  Cherry Street Public House opens in new Pioneer Square Weyerhaeuser building (Photos) at bizjournals.com
Feb-13-17 02:59PM  Weyerhauser Is Making an (Upside) Break For It
Feb-10-17 11:36AM  This Global Paper Giant Looks Promising
01:33AM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Feb-08-17 11:21AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017
Feb-07-17 09:36AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017
Feb-03-17 08:11PM  Edited Transcript of WY earnings conference call or presentation 3-Feb-17 3:00pm GMT
09:31AM  Weyerhaeuser (WY) Misses Q4 Earnings by a Penny; Sales Lag
07:25AM  Market Recon: The Fear of Stagflation Keeps Me Up at Night
07:07AM  Q4 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00AM  Weyerhaeuser misses 4Q profit forecasts
04:40AM  Weyerhaeuser (WY) Misses on Q4 Earnings and Revenues
03:05AM  Weyerhaeuser reports fourth quarter, full year results PR Newswire
Feb-02-17 07:03PM  International Paper CEO explains what really triggered sh...
04:42PM  This Timber REIT Is a Solid Buy Amidst Spike in Housing, Construction
08:46AM  Why Earnings Season Could Be Great for Weyerhaeuser Company (WY)
08:10AM  Construction Stocks Reporting Q4 Earnings on Feb 3: WY, OSB
Feb-01-17 06:24AM  Weyerhaeuser's (WY) Q4 Earnings: Is a Beat in the Cards?
Jan-26-17 06:48AM  Great Lakes Announces Changes to Board of Directors GlobeNewswire
Jan-25-17 07:50AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : January 25, 2017
Jan-17-17 04:15PM  Weyerhaeuser announces tax treatment of 2016 distributions PR Newswire
Jan-09-17 08:25AM  Weyerhaeuser upgraded by Raymond James
Jan-06-17 11:40AM  U.S. makes early finding of injury from some softwood lumber from Canada Reuters
07:32AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : January 6, 2017
07:15AM  Weyerhaeuser's (WY) Long-Term Prospects Dimmed by Risks
Jan-03-17 04:49PM  Weyerhaeuser to release fourth quarter results on Feb. 3 PR Newswire
Dec-19-16 12:30PM  Federal Way mulls development moratorium after Weyerhaeuser campus deal falls through at bizjournals.com
Dec-17-16 08:25AM  3 Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Dec-16-16 07:34AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 16, 2016
Dec-14-16 10:20AM  5 Companies Hit 52-Week Highs
Dec-06-16 05:04PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
05:57AM  Trump's Policies Are Pushing These 5 Industrials Into Breakout Territory
Dec-04-16 09:34PM  Is Weyerhaeuser Co (WY) A Good Stock To Buy Right Now? at Insider Monkey
Dec-02-16 08:45AM  Weyerhaeuser Divests Cellulose Fibers Business for $2.2B
Dec-01-16 09:36AM  Weyerhaeuser completes sale of Cellulose Fibers pulp mills to International Paper PR Newswire
07:29AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 1, 2016
Nov-29-16 10:02AM  Hate Checking Your Portfolio? Try These 3 Stocks at Motley Fool
Nov-24-16 12:12PM  Hilton Worldwide Holdings Inc (HLT): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-22-16 12:29PM  ETFs with exposure to Weyerhaeuser Co. : November 22, 2016
Nov-21-16 07:08AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : November 21, 2016
Nov-14-16 12:26PM  5 Top Construction Stocks for the Housing Rebound at Motley Fool
Nov-09-16 10:16AM  Four Global Natural Resource Plays That Are Attractive From the Long Side of the Charts
Nov-07-16 04:35PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
Nov-03-16 01:04PM  WEYERHAEUSER CO Financials
Nov-02-16 07:19AM  Weyerhaeuser Boosts Core Business with North Pacific Sale
Nov-01-16 04:30PM  Weyerhaeuser completes sale of printing papers business to an affiliate of One Rock Capital Partners PR Newswire
03:28PM  Paper: The Technology That Refuses To Die at Forbes
12:44PM  ETFs with exposure to Weyerhaeuser Co. : November 1, 2016
Oct-31-16 08:00PM  Weyerhaeuser announces leadership changes PR Newswire
05:55PM  RANKED: Highest-paid lobbying firms in Washington state and who's paying them at bizjournals.com
10:02AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
06:30AM  Weyerhaeuser Stock Slips on Q3 Revenue Miss (WY) at Investopedia
Oct-29-16 02:21PM  Highlights From Third Avenues Investor Letters at Insider Monkey
Oct-28-16 01:01PM  Edited Transcript of WY earnings conference call or presentation 28-Oct-16 2:00pm GMT
09:02AM  Weyerhaeuser (WY) Beats Q3 Earnings, Lags on Revenues
07:07AM  Q3 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:03AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:03AM  Weyerhaeuser tops 3Q profit forecasts
04:01AM  Weyerhaeuser (WY) Beats on Q3 Earnings, Lags on Revenues
03:05AM  Weyerhaeuser reports third quarter results PR Newswire
Oct-27-16 04:00PM  Timber-r-r-r ... Lumber Plays Getting Felled
11:25AM  After second quarter payouts, International Paper posts strong third quarter at bizjournals.com
10:31AM  Weyerhaeuser Co. : WY-US: Dividend Analysis : October 28th, 2016 (record date) : By the numbers : October 27, 2016
07:50AM  Construction Stocks' Q3 Earnings to Watch on Oct 28: WY, GVA
Oct-26-16 08:11AM  Weyerhaeuser (WY) to Report Q3 Earnings: What to Expect?
Oct-25-16 08:35PM  Bill Bryant's top donors include Paccar CEO, Weyerhaeuser heir and Martin Selig at bizjournals.com
08:21PM  Gov. Jay Inslee's top donors include Mariners, Michael Bloomberg and Amazon execs at bizjournals.com
Oct-24-16 03:50PM  Weak industrial earnings, cause for concern?
Oct-20-16 06:42AM  Universal Forest (UFPI) Hikes Semi-Annual Dividend By 7%
Oct-18-16 08:12AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : October 18, 2016
Oct-14-16 05:16PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Oct-13-16 07:58AM  Weyerhaeuser (WY) to Strategically Review Assets in Uruguay
Oct-12-16 01:23PM  Traders turn bullish on Weyerhaeuser
08:50AM  [$$] Weyerhaeuser Explores Sale of Uruguay Business at The Wall Street Journal
07:07AM  Weyerhaeuser explores sale of Uruguay timber business
06:30AM  Weyerhaeuser to explore strategic alternatives for its Uruguay timberlands and manufacturing business PR Newswire
Oct-11-16 05:25PM  Weyerhaeuser shows off its new 'tree fort' headquarters in Seattle's Pioneer Square (Photos) at bizjournals.com
Oct-10-16 09:28AM  Weyerhaeuser's (WY) Growth Prospects Offset by Headwinds
Oct-06-16 10:19AM  Stock Market News for October 06, 2016
07:23AM  These 5 Big Stocks Are Breaking Out in October
06:58AM  Weyerhaeuser (WY) to Divest North Pacific to One Rock
Oct-05-16 10:24AM  [$$] Weyerhaeuser Sells Printing-Papers Business at The Wall Street Journal
08:31AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : October 5, 2016
01:10AM  Weyerhaeuser to sell printing papers business to One Rock Capital Partners PR Newswire
Sep-30-16 04:30PM  Weyerhaeuser to release third quarter results on Oct. 28 PR Newswire
Sep-23-16 08:58AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : September 23, 2016
Sep-22-16 04:13PM  The Hot Stock: Weyerhaeuser Gains 5.7% Because That's the Power of Goldman Sachs at Barrons.com +5.74%
01:57PM  Reaction to Weyerhaeuser (WY) 'Buy' Rating at Goldman
12:35PM  Call of the day: Weyerhaeuser & SeaWorld
12:30PM  Goldman Neutral On Paper/Forest Products: Prefers Boise Cascade, Weyerhauser
08:55AM  Weyerhaeuser (WY) Stock Climbs, Gets 'Buy' Rating at Goldman
07:57AM  Early movers: AZO, RAD, CBS, SEAS, BBBY, YHOO, WCIC, JBL, RHT, LMT & more at CNBC
Sep-21-16 07:19PM  Cramer: Don't sweat it, this stock goes to $200 in the long run at CNBC
Sep-20-16 10:43AM  Strong Housing Starts And Chinese Demand Bode Well For Weyerhaeuser
Sep-01-16 10:13AM  Top Research Reports for 1st September, 2016
10:10AM  Stock Market News for September 01, 2016
06:46AM  Weyerhaeuser (WY) Sells Liquid Packaging Facility to Nippon
Aug-31-16 04:30PM  Weyerhaeuser Completes Sale of Liquid Packaging Board Business to Nippon Paper Industries PR Newswire
Aug-30-16 11:50AM  These Seemingly Boring Investments Can Generate Exciting Returns
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunter Rhonda DSr. Vice PresidentFeb 21Option Exercise24.1614,099340,63288,510Feb 22 07:50 PM
Hunter Rhonda DSr. Vice PresidentFeb 21Sale34.0014,099479,36674,411Feb 22 07:50 PM
Merle Denise MSenior Vice PresidentFeb 14Sale33.5237412,53636,185Feb 15 07:53 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 13Option Exercise28.1836,9341,040,89196,747Feb 15 07:17 PM
Merle Denise MSenior Vice PresidentFeb 13Sale33.281,34944,89636,559Feb 15 07:53 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 13Sale33.9036,9341,252,14059,134Feb 15 07:17 PM
Merle Denise MSenior Vice PresidentFeb 10Sale33.091,23340,80038,877Feb 14 03:33 PM
Hunter Rhonda DSr. Vice PresidentFeb 02Option Exercise30.392,19066,55261,406Feb 03 07:44 PM
Merle Denise MSenior Vice PresidentFeb 02Option Exercise30.395,176157,29336,735Feb 03 07:45 PM
Merle Denise MSenior Vice PresidentFeb 02Sale30.985,176160,35231,559Feb 03 07:45 PM
Hunter Rhonda DSr. Vice PresidentFeb 02Sale30.982,19067,84659,216Feb 03 07:44 PM
Hagen Russell SSenior Vice President and CFOJan 12Option Exercise25.279,600242,59289,763Jan 13 02:06 PM
Merle Denise MSenior Vice PresidentDec 08Option Exercise23.566,503153,19138,062Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentDec 08Sale33.006,503214,59931,559Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentOct 10Option Exercise18.3711,420209,73746,404Oct 12 06:12 PM
Merle Denise MSenior Vice PresidentOct 10Sale31.1215,049468,32531,355Oct 12 06:12 PM
Slater Catherine ISenior Vice PresidentAug 12Sale31.8111,609369,29470,466Aug 16 03:14 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Option Exercise16.8059,6861,002,921110,432Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Sale32.5859,6861,944,52850,746Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Option Exercise9.534,49242,80055,238Aug 10 08:28 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Sale32.504,492145,99050,746Aug 10 08:28 PM
Hunter Rhonda DSr. Vice PresidentJul 27Option Exercise23.563,31878,16261,768Jul 27 09:06 PM
Hunter Rhonda DSr. Vice PresidentJul 27Sale33.003,318109,49458,450Jul 27 09:06 PM
HOLLEY RICK RDirectorJul 26Option Exercise24.11181,0434,364,595735,113Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 26Sale32.64181,0435,909,092554,070Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Option Exercise24.41426,95710,423,885981,027Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Sale32.51426,95713,881,368554,070Jul 27 06:46 PM
Hunter Rhonda DSr. Vice PresidentJun 30Option Exercise20.423,29267,22361,742Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 30Sale30.003,29298,76058,450Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 20Sale29.126,500189,28058,019Jun 22 03:35 PM
Bozeman David PDirectorJun 09Sale30.301,92958,4566,262Jun 13 12:42 PM
Emmert Mark ADirectorJun 07Sale31.259,536298,0009,715Jun 08 07:56 PM
CELG Celgene Corporation daily Stock Chart
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E47.98 EPS (ttm)2.49 Insider Own0.20% Shs Outstand776.90M Perf Week1.92%
Market Cap92.66B Forward P/E13.60 EPS next Y8.77 Insider Trans24.96% Shs Float775.87M Perf Month6.20%
Income2.00B PEG2.15 EPS next Q1.63 Inst Own79.60% Short Float0.95% Perf Quarter-2.21%
Sales11.23B P/S8.25 EPS this Y28.10% Inst Trans1.08% Short Ratio1.74 Perf Half Y4.44%
Book/sh8.49 P/B14.05 EPS next Y21.47% ROA7.40% Target Price141.22 Perf Year16.89%
Cash/sh10.26 P/C11.63 EPS next 5Y22.28% ROE35.00% 52W Range94.39 - 127.00 Perf YTD3.04%
Dividend- P/FCF24.77 EPS past 5Y11.80% ROI11.70% 52W High-6.09% Beta1.77
Dividend %- Quick Ratio3.50 Sales past 5Y18.30% Gross Margin96.10% 52W Low26.36% ATR2.28
Employees7132 Current Ratio3.70 Sales Q/Q16.30% Oper. Margin25.00% RSI (14)57.33 Volatility2.24% 1.96%
OptionableYes Debt/Eq2.17 EPS Q/Q-22.20% Profit Margin17.80% Rel Volume0.90 Prev Close119.44
ShortableYes LT Debt/Eq2.09 EarningsJan 26 BMO Payout0.00% Avg Volume4.25M Price119.27
Recom1.80 SMA202.70% SMA502.49% SMA2009.04% Volume3,830,753 Change-0.14%
Nov-09-16Downgrade Standpoint Research Buy → Hold
Nov-08-16Initiated Mizuho Buy $130
Jul-15-16Initiated Stifel Buy $138
Apr-29-16Reiterated Sun Trust Rbsn Humphrey Buy $145 → $147
Feb-25-16Initiated Citigroup Buy $130
Jan-20-16Initiated Credit Suisse Outperform
Jan-14-16Initiated Standpoint Research Buy $130
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $145
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Nov-06-15Reiterated UBS Buy $156 → $145
Oct-01-15Upgrade JP Morgan Neutral → Overweight
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $160
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Feb-25-15Reiterated Argus Buy $130 → $155
Feb-22-17 04:02PM  FDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Business Wire
06:43AM  Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb-21-17 07:01PM  3 Great Stocks to Buy Instead of NVIDIA Corporation at Motley Fool
08:15AM  Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results Accesswire
06:00AM  [$$] US exporters line up behind tax code overhaul at Financial Times
Feb-20-17 10:30AM  Celgene MS Drug Reports Positive Phase 3 Data at Investopedia
08:24AM  3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter at Motley Fool
07:52AM  Forget Alexion, Buy these 4 Biotech Stocks Instead
Feb-19-17 11:41AM  Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands? at Motley Fool
Feb-17-17 04:15PM  Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?
01:30PM  Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases
08:39AM  Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
08:14AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
07:30AM  Celgene Announces Positive Results from Phase III SUNBEAM Trial of Oral Ozanimod in Patients with Relapsing Multiple Sclerosis Business Wire
Feb-16-17 02:39PM  3 Biotechs With Tremendously Promising Pipelines at Motley Fool
08:53AM  Agios (AGIO) Q4 Loss Narrower than Expected; Revenues Up Y/Y
Feb-15-17 06:35PM  Cramer fires back at naysayers: Here's your proof that th...
06:22PM  Cramer fires back at naysayers: Here's your proof that this rally is real at CNBC
05:59PM  Proof the rally is real
01:04PM  CELGENE CORP /DE/ Financials
10:56AM  Celgene Could Have One More Powerful Move Higher
09:48AM  Want to Get In on Biotech? Check Out These 3 Stocks at Motley Fool
Feb-14-17 03:10PM  Some of biotech's biggest names have acquired this Md. company at bizjournals.com
10:28AM  3 Top Biotech Stocks to Buy on Sale at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics
08:33AM  Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 14, 2017
Feb-13-17 03:52PM  Key Presenters At Leerink's Healthcare Conference
02:25PM  Regeneron: It's All Riding On Dupixent at Barrons.com
11:31AM  How one stock changed my life
09:14AM  Forget Gilead, Buy These 5 Biotech Stocks Instead
Feb-10-17 04:14PM  Is Biogen a Risky Stock? at Motley Fool
12:01PM  3 Stocks We'd Buy and Hold for the Next 20 Years at Motley Fool
09:55AM  Major Biotechs Scare Off Loads of Short Sellers
08:38AM  Biotech ETFs Powered by Q4 Earnings
06:03AM  CELGENE CORP /DE/ Files SEC form 10-K, Annual Report
Feb-09-17 03:21PM  Why bluebird bio Stock Surged 20.7% Higher in January at Motley Fool
Feb-08-17 09:30AM  The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma
09:30AM  The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals
08:23AM  Better Buy: Amgen Inc. vs. Celgene at Motley Fool
Feb-07-17 03:26PM  5 Great Biotech Stocks to Buy Now
09:06AM  Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More
07:41AM  4 Drug Stocks that are Broker Favorites
Feb-06-17 08:45AM  Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More
07:45AM  3 Stocks That Could Make You Rich at Motley Fool
Feb-03-17 10:32AM  ETFs with exposure to Celgene Corp. : February 3, 2017
07:30AM  Celgene Corporation to Webcast at Upcoming Investor Conference Business Wire
Feb-02-17 05:32PM  Biogen: What Now? at Barrons.com
04:23PM  Celgene Subsidiary Invests in Jounce Therapeutics
04:01PM  House Panel to Take Up Trump's Call to Speed FDA Approvals
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, PayPal, Thermo Fisher, Celgene and American Airlines
08:02AM  What Could Make Biogen Crash? at Motley Fool
07:35AM  Understanding Celgenes Operational Performance Projections for 2017
07:27AM  Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : February 2, 2017
06:27AM  Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data
Feb-01-17 04:12PM  Roche CEO Shrugs Off Trump's Drug Stance; 2016 Sales Narrowly Miss
03:17PM  Top Research Reports for February 1, 2017
10:36AM  Celgenes Big Plans for Otezla in 2017
09:30AM  The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals
09:06AM  Why Celgenes Otezla Is Expected to See Strong Demand Trends in 2017
07:36AM  Behind Celgenes Blockbuster Revenue Hit in 4Q16
07:14AM  Drug Stocks Rally on Trump Meet with Pharma Bigwigs
Jan-31-17 04:17PM  Fmr. Onyx CEO: Responsibility to find and research cures ...
12:34PM  Unusual activity: Bulls bet on Celgene & Potash
10:37AM  Celgenes Abraxane Sees Stable Demand in 4Q16
10:37AM  Trump, at Biopharma Meeting, Pledges to 'Streamline' FDA, Cut Regulations but Wants Lower Prices
10:33AM  Trump pushes drugmakers for lower prices, more U.S. production Reuters
10:15AM  4 Top Biotech Stocks With Big Upcoming Catalysts
09:07AM  Inside Celgenes Pomalyst: A Solid Growth Trend in 4Q16
07:38AM  Inside Celgenes Revlimid: Strong Patient Demand in 4Q16
07:30AM  7 Top Stocks to Buy in February at Motley Fool
06:43AM  4 FDA Decisions to Watch Out for in Feb 2017
Jan-30-17 04:05PM  Understanding Celgenes Robust Profit Margin Rise in 4Q16
02:36PM  Celgenes Financial Performance in 2016: Strong Growth in Volumes
12:54PM  Celgene Reported Robust Revenue Growth in 4Q16
10:20AM  Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid
09:40AM  Celgene Corp. :CELG-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017
08:22AM  3 Top Pharmaceutical Stocks to Buy in February at Motley Fool
Jan-28-17 12:01PM  How Big Is the Opportunity for Celgene's Otezla Overseas? at Motley Fool
08:28AM  3 Most Unbelievably Undervalued Biotech Stocks at Motley Fool
Jan-27-17 01:44PM  Celgene Corporation (CELG) To Acquire Autoimmune Firm Delinia For $775 Million at Insider Monkey
01:28PM  Celgene Corporation Continues Its Double-Digit Growth at Motley Fool
08:15AM  Blog Coverage Celgene Acquires Delinia; Set to Expand Inflammation and Immunology Portfolio Accesswire
07:17AM  Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide) Indication as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma (MM) after Autologous Stem Cell Transplantation Business Wire
06:15AM  Cambridges Jounce raises hopes as first Mass. biotech of 2017 to go public at bizjournals.com
01:24AM  Gilead Sciences Expected to Witness Drop in Revenues in 2017
Jan-26-17 08:12PM  Edited Transcript of CELG earnings conference call or presentation 26-Jan-17 2:00pm GMT
05:15PM  [$$] Celgene To Acquire Biotech Startup Delinia For Up to $775 Million at The Wall Street Journal
05:06PM  Celgene Aims To Hurdle Revlimid Patent Loss By Growing EPS Annually
04:41PM  Celgene's Fastest-Growing Drugs at Motley Fool
03:29PM  Celgene (CELG) Misses on Earnings & Revenues, Keeps View
01:21PM  Biotech ETFs: Is It Time To Buy? at Barrons.com
11:01AM  Why Celgene is Tumbling at Barrons.com
10:38AM  Celgene's 2% share decline may be due to disappointing 2020 guidance, analyst says at MarketWatch
10:35AM  Short Sellers Back Off Major Biotechs
10:32AM  Celgene (CELG) Misses On Q4 Earnings & Revenues
10:26AM  Celgene Shares Sink Despite 36% Earnings Growth
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb
08:12AM  [$$] Celgene Revenue Rises on Revlimid Strength at The Wall Street Journal
07:50AM  Celgene beats 4Q profit forecasts
07:37AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, and ankylosing spondylitis; and ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers. The company's products also include VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and acute myeloid leukemia (AML); THALOMID to treat patients with multiple myeloma and erythema nodosum leprosum; and RITALIN and FOCALIN XR products. Its clinical stage products comprise OTEZLA for use in treating various immune-inflammatory diseases; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; AG-881 for glioma with IDH mutations; LSD1 inhibitor to treat non-hodgkin lymphoma and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; and durvalumab, an anti-PDL-1 antibody, for multiple hematological cancers. The company has collaborative agreements with Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; Nurix Inc.; and Jounce Therapeutics, Inc.; The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VESSEY RUPERTSee remarksFeb 02Option Exercise0.005,62306,773Feb 06 04:14 PM
Celgene Switzerland LLC10% OwnerFeb 01Buy16.00625,00010,000,0003,456,463Feb 01 04:18 PM
HUGIN ROBERT Jsee remarksJan 05Option Exercise27.4322,708622,767913,909Jan 09 04:11 PM
Smith Scott AndrewSee RemarksDec 23Option Exercise0.006,400039,875Dec 27 04:17 PM
PEHL MICHAEL F.See remarksDec 02Option Exercise0.001,88001,880Dec 06 04:05 PM
Smith Scott AndrewSee RemarksDec 02Option Exercise0.003,750035,419Dec 06 04:05 PM
FOUSE JACQUALYN Asee remarksDec 02Option Exercise0.005,000084,392Dec 06 04:04 PM
Alles Mark JSee RemarksDec 02Option Exercise0.006,5600166,134Dec 06 04:03 PM
VESSEY RUPERTSee remarksNov 22Sale123.182,500307,9501,150Nov 30 04:15 PM
PEHL MICHAEL F.See remarksNov 10Option Exercise68.3920,4241,396,77022,052Nov 15 04:22 PM
PEHL MICHAEL F.See remarksNov 10Sale121.0422,0522,669,1490Nov 15 04:22 PM
Friedman Michael ADirectorNov 09Option Exercise31.8018,600591,48018,600Nov 10 04:14 PM
Friedman Michael ADirectorNov 09Sale116.1018,6002,159,4600Nov 10 04:14 PM
HUGIN ROBERT Jsee remarksNov 09Sale120.00100,00012,000,000922,201Nov 14 05:47 PM
CELGENE CORP /DE/10% OwnerOct 24Buy14.00800,15011,202,1004,834,980Oct 26 04:15 PM
CASEY MICHAEL DDirectorOct 18Option Exercise100.067,500750,45092,985Oct 19 04:16 PM
Friedman Michael ADirectorOct 03Option Exercise29.8656,1161,675,36456,116Oct 05 04:09 PM
Friedman Michael ADirectorOct 03Sale103.6656,1165,816,9850Oct 05 04:09 PM
BARKER RICHARD WDirectorSep 23Option Exercise36.9220,000738,40031,332Sep 26 04:08 PM
BARKER RICHARD WDirectorSep 23Sale110.8220,0002,216,40011,332Sep 26 04:08 PM
MARIO ERNESTDirectorSep 23Sale109.4215,0001,641,30090,058Sep 26 04:08 PM
KAPLAN GILLADirectorSep 19Option Exercise29.267,500219,45079,642Sep 20 04:42 PM
KAPLAN GILLADirectorSep 15Sale106.449,7101,033,53272,142Sep 16 04:15 PM
LOUGHLIN JAMES JDirectorAug 23Option Exercise26.3627,500724,85050,419Aug 24 04:28 PM
LOUGHLIN JAMES JDirectorAug 23Sale114.1027,5003,137,75022,919Aug 24 04:28 PM
CASEY MICHAEL DDirectorAug 22Sale114.0143,1344,917,70785,485Aug 23 04:29 PM
HUGIN ROBERT Jsee remarksJul 28Sale110.00100,00011,000,0001,022,201Aug 01 05:04 PM
MARIO ERNESTDirectorJul 01Option Exercise0.007330105,058Jul 05 04:32 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733022,919Jul 05 04:30 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 05 04:27 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733081,852Jul 05 04:28 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733023,146Jul 05 04:27 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.00733011,551Jul 05 04:25 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 05 04:26 PM
HUGIN ROBERT Jsee remarksJun 20Sale100.1675,0007,512,0001,122,201Jun 22 04:42 PM
KAPLAN GILLADirectorJun 17Option Exercise0.00333081,119Jun 17 04:18 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033300Jun 17 04:13 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033300Jun 17 04:14 PM
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.006,200022,413Jun 17 04:14 PM
KAPLAN GILLADirectorJun 15Option Exercise0.006,200080,786Jun 17 04:18 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,068021,853Jun 13 05:10 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0680103,992Jun 13 05:10 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,068074,586Jun 13 05:09 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,068011,439Jun 13 05:08 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06800Jun 13 05:08 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06800Jun 13 05:09 PM
Alles Mark JSee RemarksApr 29Option Exercise0.0011,0000164,636May 03 04:30 PM
HUGIN ROBERT Jsee remarksApr 29Option Exercise0.0060,00001,228,311May 03 04:19 PM
Smith Scott AndrewSee RemarksApr 29Option Exercise0.0010,000036,656May 03 09:28 PM
MARIO ERNESTDirectorApr 26Option Exercise31.805,000158,975101,924Apr 28 04:09 PM
KAPLAN GILLADirectorApr 04Sale101.8415,9671,626,07972,518Apr 05 04:15 PM
BONNEY MICHAEL WDirectorMar 03Buy103.012,000206,0282,000Mar 04 04:33 PM
CVS CVS Health Corporation daily Stock Chart
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E16.27 EPS (ttm)4.93 Insider Own0.10% Shs Outstand1.02B Perf Week1.89%
Market Cap81.97B Forward P/E12.62 EPS next Y6.35 Insider Trans-11.87% Shs Float1.02B Perf Month-1.34%
Income5.29B PEG1.56 EPS next Q1.11 Inst Own86.30% Short Float4.07% Perf Quarter8.92%
Sales177.53B P/S0.46 EPS this Y5.60% Inst Trans-0.84% Short Ratio5.44 Perf Half Y-17.30%
Book/sh34.61 P/B2.32 EPS next Y8.56% ROA5.70% Target Price86.34 Perf Year-15.52%
Cash/sh3.38 P/C23.71 EPS next 5Y10.40% ROE14.70% 52W Range68.88 - 105.04 Perf YTD2.20%
Dividend2.00 P/FCF13.65 EPS past 5Y13.60% ROI9.90% 52W High-23.69% Beta0.82
Dividend %2.50% Quick Ratio0.60 Sales past 5Y10.60% Gross Margin16.30% 52W Low16.37% ATR1.43
Employees158000 Current Ratio1.20 Sales Q/Q11.70% Oper. Margin5.50% RSI (14)57.96 Volatility1.16% 1.89%
OptionableYes Debt/Eq0.75 EPS Q/Q17.90% Profit Margin3.00% Rel Volume0.65 Prev Close79.76
ShortableYes LT Debt/Eq0.70 EarningsFeb 09 BMO Payout34.30% Avg Volume7.65M Price80.16
Recom2.00 SMA202.44% SMA500.98% SMA200-8.39% Volume4,972,736 Change0.50%
Feb-06-17Downgrade Atlantic Equities Overweight → Neutral
Feb-02-17Downgrade Robert W. Baird Outperform → Neutral $86 → $77
Dec-12-16Downgrade Jefferies Buy → Hold
Nov-09-16Reiterated Mizuho Buy $111 → $90
Aug-04-16Reiterated Mizuho Buy $108 → $111
Aug-03-16Reiterated Deutsche Bank Hold $99 → $108
Jun-23-16Reiterated Mizuho Buy $117 → $108
Jun-22-16Reiterated Deutsche Bank Hold $105 → $99
Jun-20-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-04-16Reiterated RBC Capital Mkts Outperform $110 → $115
May-04-16Reiterated Mizuho Buy $104 → $117
Mar-10-16Reiterated Barclays Overweight $110 → $115
Feb-10-16Reiterated Mizuho Buy $113 → $104
Feb-03-16Initiated Atlantic Equities Overweight
Jan-22-16Initiated Robert W. Baird Outperform $108
Dec-18-15Resumed Barclays Overweight $110
Dec-17-15Reiterated Oppenheimer Outperform $115 → $117
Dec-17-15Downgrade Goldman Buy → Neutral
Aug-28-15Reiterated Oppenheimer Outperform $122 → $119
Aug-10-15Reiterated Argus Buy $114 → $118
Feb-22-17 11:50AM  Here are the winners and losers under President Trump's first month
09:31AM  CVS removes artificial trans fats from its food brands Reuters
08:53AM  CVS says it has removed artificial trans fat contributor from all exclusive store brands, in advance of mid-2018 deadline at MarketWatch
08:40AM  CVS Pharmacy Is First National Retail Pharmacy to Remove Artificial Trans Fats from All Exclusive Store Brand Food Products PR Newswire
08:15AM  Post Earnings Coverage as Express Scripts' Adjusted EPS Gained 21%; Adjusted EBITDA per Adjusted Claim up 14% Accesswire
Feb-17-17 12:27PM  It Has Worked: CVS Health Corp (CVS) Says Of Its Exit Of Cigarette Business at Insider Monkey
Feb-16-17 04:29PM  CVS Health And Breathe California Announce Statewide Finalists In Student Film Contest On Youth Smoking PR Newswire
04:01PM  CVS Health Research Institute Study Confirms that the Company's Tobacco Removal Decision Reduced Cigarette Purchases Nationwide PR Newswire
01:49PM  The Experts Say You Should Buy These Stocks. So Should You? at Insider Monkey
12:23PM  2 Stocks To Buy And Hold For The Next 2 Years at Forbes
10:23AM  FORTUNE® Recognizes CVS Health on List of "World's Most Admired Companies" PR Newswire
08:39AM  3 Bargain Stocks You Can Buy Today at Motley Fool
Feb-15-17 03:52PM  Hill: GD & CVS will benefit from Trump administration
01:04PM  CVS HEALTH CORP Financials
12:02PM  Express Scripts: Rx For Earnings Growth
08:23AM  4 Stocks to Buy Near 52-Week Lows at Motley Fool
Feb-14-17 07:26PM  George Soros Builds Stake in Goldman Sachs, Cuts BofA at The Wall Street Journal
04:13PM  Better Buy: CVS Health Corporation vs. Express Scripts at Motley Fool
03:37PM  ETFs with exposure to CVS Health Corp. : February 14, 2017
11:45AM  Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
10:41AM  "Made in the USA" lawsuit against CVS Health is dismissed
Feb-13-17 10:43AM  CVS Health Corp. :CVS-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017
09:30AM  CVS Health Earns CEO Cancer Gold Standard Accreditation PR Newswire
08:00AM  MinuteClinic to Offer Free "Know Your Numbers" Screenings on Valentine's Day at Locations Nationwide PR Newswire
Feb-10-17 03:46PM  5 Things CVS Health Management Said That You'll Want to Know at Motley Fool
03:12PM  Two Dozen Dividend Growth Superstar Stocks That Look Cheap at Forbes
09:08AM  CVS Health Corp. :CVS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 10, 2017
08:45AM  PBMs are able to negotiate on drug prices: Dave Dorman
Feb-09-17 06:15PM  Edited Transcript of CVS earnings conference call or presentation 9-Feb-17 1:30pm GMT
05:32PM  WellDyneRx, LLC -- Moody's affirms WellDyneRx's first lien bank rating at B3; Caa1 CFR at Moody's
04:03PM  CVS Health Earnings Growth Tops, But Sales Miss Estimates
02:48PM  CVS Remains Unsure About the Future of Obamacare, CEO Says
01:25PM  What Is Driving CVS Revenue Growth?
01:22PM  [$$] CVS Profit Rises, Helped by Pharmacy Strength at The Wall Street Journal
01:05PM  CVS Health Tops Expectations in Q4 Thanks to CareMark PBM at Motley Fool
12:26PM  CVS defends PBM industry against drug price hikes
12:02PM  CVS Health beats 4Q profit forecasts, affirms 2017 forecast
10:03AM  Pharmacy Services Boost CVS Amid Drug Pricing Battle at Forbes
09:50AM  CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View
09:14AM  5 Stocks For 17% Returns This Year (& Beyond) at Forbes
08:28AM  CVS Health Tops Q4 Earnings, Misses on Revenues
08:26AM  Market Recon: This Barbarous Relic Has Been Seriously Hot Lately
07:51AM  Early movers: KO, TWTR, VIAB, CVS, YUM, RAI, & more at CNBC
07:12AM  CVS shares gain 2% after Q4 profit beats expectations at MarketWatch
07:07AM  Q4 2016 CVS Health Corp Earnings Release - Before Market Open
07:00AM  CVS Health quarterly revenue rises 11.7 pct
06:59AM  CVS HEALTH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
06:55AM  CVS Health Reports Record Fourth Quarter And Full Year Results For 2016; Confirms 2017 EPS Guidance PR Newswire
04:44AM  CVS Looks to Shed Light on Trump-Effect on PBMs
Feb-08-17 05:33PM  'Dark shadows' What you need to know in markets on Thursday
03:24PM  Nvidia, Twitter, Yum, CVS, Expedia Lead Investing Action Plan
01:44PM  Deutsche Bank Does Some DIY Math On CVS And The PBM Question
11:05AM  Top 7 Earnings Reports to Watch For on Thursday
09:14AM  3 Reasons CVS Health Corporation Stock Could Fall at Motley Fool
07:11AM  Earnings Preview: What To Expect From CVS On Thursday at Forbes
Feb-07-17 03:54PM  The US stock market is 'fragile' right now, expert says at CNBC
09:10AM  CyberArk Software (CYBR) Q4 Earnings: What's in the Cards?
08:57AM  Weitz Investment Looks to Visa (V), Amazon (AMZN), Others for Big Returns After Subpar 2016 at Insider Monkey
06:51AM  What's working: Four long-term stock plays
Feb-06-17 04:50PM  Is 2017 the Year of the Retail Famine?
09:07AM  CVS Health downgraded by Atlantic Equities
08:45AM  Paycom Software (PAYC) Q4 Earnings: What's in the Cards?
07:45AM  3 Stocks That Could Make You Rich at Motley Fool
Feb-04-17 02:47PM  3 Key Things to Watch in CVS Health's Q4 Update at Motley Fool
Feb-03-17 11:45AM  How Risky Is CVS Health Corporation? at Motley Fool
08:20AM  CDW Corp. (CDW) Q4 Earnings: What's in the Cards this Time?
Feb-02-17 10:21AM  CVS' Exposure To Drug Pricing And PBM Debate Casts A Shadow On The Outlook
08:40AM  Merrill Lynch Out With Top Sector Picks for 2017: 7 to Buy Now
Feb-01-17 10:02AM  Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings? (Revised)
09:59AM  Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)
08:30AM  CVS Health Announces Support of Women's Heart Health with $10 Million Commitment to Go Red For Women® PR Newswire
Jan-31-17 08:35AM  Merrill Lynch Says 5 Companies Could Benefit Huge From Trump Tax Plan 24/7 Wall St.
Jan-30-17 01:03PM  [$$] Walgreens Boots Alliance: range rover at Financial Times
12:40PM  CVS Health Short Interest Surges 234% at Investopedia
12:00PM  CVS Health Corporation To Hold Fourth Quarter 2016 Conference Call PR Newswire
08:46AM  CVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : January 30, 2017
08:29AM  Gigamon (GIMO) to Report Q4 Earnings: Will it Disappoint?
07:47AM  NXP Semiconductors (NXPI) Q4 Earnings: Will it Surprise?
Jan-28-17 12:01AM  [$$] Barron's Roundtable, Part 3: Digging Into the Details at Barrons.com
Jan-27-17 05:12PM  Express Scripts Falls on Attack From Andrew Left
09:46AM  Is Disappointment in Store for Aetna (AET) in Q4 Earnings?
08:47AM  CVS Health (CVS) Q4 Earnings: A Beat in Store for the Stock?
Jan-26-17 06:00PM  WD Wolverine Holdings, LLC -- Moody's downgrades WD Wolverine's CFR to Caa1 at Moody's
03:17PM  Weitz Funds Comments on CVS Health
01:00PM  Weitz Investment Management's Value Fund 4th Quarter Commentary Gurufocus
12:30PM  Big companies' share prices went up, but not in this one industry at bizjournals.com
Jan-25-17 02:28PM  Could Pharmacy Benefit Managers Be Trump's Next Target?
01:35PM  Retail store closings pile up as 2017 kicks into full gear at bizjournals.com
10:36AM  Teladoc (TDOC) to Report Q4 Earnings: What's in Store?
Jan-24-17 09:50AM  These 85 stocks are now on a buy list as Donald Trump takes office at MarketWatch
Jan-23-17 04:24PM  Aetna May Not Be Ready to Scrap Its Scuttled $37 Billion Humana Tie-up
11:03AM  [$$] Why Adamis Tops Impax Syringe at CVS Health at Barrons.com
Jan-20-17 04:27PM  Walgreens Falls, Rite Aid Dives As FTC Reportedly Opposes Merger Offer
11:42AM  CVS Health Corporation in 4 Charts at Motley Fool
Jan-19-17 06:50PM  Coca-Cola's 'threatening' downgrade makes Jim Cramer want to buy this beverage stock at CNBC
03:56PM  CVS Health Stock Trades Ex-Dividend Friday at Investopedia
Jan-18-17 09:56AM  3 Reasons CVS Health Corporation Stock Could Rise at Motley Fool
09:00AM  Retail Clinic Use Soars But Not For Obamacare Patients at Forbes
08:25AM  Better Buy: CVS Health Corporation vs. Kroger at Motley Fool
08:15AM  Post Earnings Coverage as UnitedHealth Group Earnings Surged 56% Accesswire
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,709 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y mas, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 38 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts Jonathan CEVP & President, CVS CaremarkFeb 16Option Exercise36.2361,1962,217,13189,955Feb 17 04:10 PM
Roberts Jonathan CEVP & President, CVS CaremarkFeb 16Sale80.0061,1964,895,68028,759Feb 17 04:10 PM
MERLO LARRY JPresident and CEOFeb 01Option Exercise36.2376,4942,771,378318,706Feb 03 04:11 PM
MERLO LARRY JPresident and CEOFeb 01Sale78.3276,4945,991,010242,212Feb 03 04:11 PM
MERLO LARRY JPresident and CEOMay 05Option Exercise36.2338,2471,385,689280,381May 06 04:26 PM
GOLD STEPHEN JEVP & CIOMay 05Option Exercise47.299,798463,34731,358May 06 04:29 PM
GOLD STEPHEN JEVP & CIOMay 05Sale105.009,7981,028,79021,560May 06 04:29 PM
Brennan Troyen AEVP and Chief Medical OfficerMay 05Sale105.007,517789,28569,601May 06 04:28 PM
MERLO LARRY JPresident and CEOMay 05Sale105.0038,2474,015,935242,134May 06 04:26 PM
GOLD STEPHEN JEVP & CIOApr 01Option Exercise47.2921,9221,036,69142,048Apr 05 06:39 PM
Sussman AndrewEVP & Pres, CVS MinuteClinicApr 01Sale105.002,844298,62011,041Apr 05 07:21 PM
GOLD STEPHEN JEVP & CIOApr 01Sale105.0021,9222,301,81020,126Apr 05 06:39 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 09Sale100.006,755675,50069,601Mar 11 04:08 PM
XLV Health Care Select Sector SPDR ETF daily Stock Chart
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.39%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month6.23%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter6.46%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.27 Perf Half Y-0.02%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year13.09%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range64.26 - 75.38 Perf YTD7.17%
Dividend1.16 P/FCF- EPS past 5Y- ROI- 52W High-1.98% Beta-
Dividend %1.57% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low14.96% ATR0.61
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)76.54 Volatility0.87% 0.87%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.74 Prev Close73.99
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume8.94M Price73.88
Recom- SMA203.37% SMA504.87% SMA2004.25% Volume6,592,386 Change-0.15%
Feb-22-17 01:51PM  Goldman Says Buy Health-Care, Retail Volatility Before Trump Address at The Wall Street Journal
Feb-21-17 03:19PM  This Medical Device ETF Is Healthier Than its Sector at Investopedia
01:35PM  Goldman Sachs and the Proposed Repeal of Obamacare
Feb-17-17 03:58PM  Pisani: Trump rally still in tact
10:36AM  Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017
Feb-16-17 11:26AM  Consumer watchdog agency to be axed by Republican lawmakers
11:18AM  Health Care ETF Has Been Ailing
09:12AM  Obamacare's end could produce some surprise stock winners at CNBC
Feb-15-17 02:51PM  U.S. hospital stocks start 2017 strong as some Obamacare fears ease Reuters
Feb-10-17 12:00PM  A Sound Diagnosis for this Healthcare ETF at Investopedia
Feb-09-17 09:30AM  Zacks Market Edge Highlights: Health Care SPDR ETF, iShares NASDAQ Biotechnology ETF, Acadia, Aetna and Gilead
07:37AM  Did the January Jobs Report Improve Confidence in the US Economy?
Feb-08-17 03:33PM  Finding the Best Value Investment in Healthcare at Investopedia
12:51PM  Trying To Beat The Market With Index ETFs Is Alive and Well
09:02AM  Your first trade for Wednesday, February 8 at CNBC
07:36AM  What Bill Miller Thinks about Valeant Pharmaceuticals
Feb-07-17 07:47PM  Healthcare Stocks: The Buying Opportunity of the Year?
05:59PM  Final Trade: GM, NFLX & more
Feb-06-17 05:06PM  UBS: A correction is coming
12:40PM  Priced like an automaker, sputtering Gilead shares lure value bets
08:27AM  A Bull Call On A Marquee Healthcare ETF
Feb-03-17 06:11PM  Trading Friday's rally: 6 plays at CNBC
05:00PM  Trading today's rally: 6 plays
Feb-02-17 07:00AM  Merck matches profit expectations but sales come up a bit short at MarketWatch
Feb-01-17 01:10PM  How to Play Pfizer's Fourth-Quarter Results With ETFs
09:06AM  Your first trade for Wednesday, February 1 at CNBC
Jan-31-17 05:59PM  Final Trade: FDX, FCX & more
05:36PM  Humira Witnessed Solid Revenue Growth in 4Q16
10:37AM  What Are Merck & Co.s Expected Growth Drivers in 4Q16?
10:37AM  Celgenes Abraxane Sees Stable Demand in 4Q16
09:08AM  Biosimilar Segment May Drive Biogens Revenue Growth
09:07AM  Bristol-Myers Squibbs Virology Segment Is Facing Competition
08:57AM  Healthcare Q4: Eli Lilly Beats, Pfizer Misses
06:57AM  Pfizer's stock drops after profit miss, downbeat sales outlook at MarketWatch
Jan-30-17 07:37AM  TAF-Based HIV Strategy May Boost Gilead Sciencess Long-Term Growth
Jan-27-17 12:46PM  Dow 20,000 notwithstanding, the stock markets momentum is unstoppable now at MarketWatch
09:05AM  What to Expect from Eli Lillys Elanco in 4Q16
07:34AM  On Obamacare, President Trump told Republicans let it explode at MarketWatch
Jan-26-17 06:58PM  The Most Important Market in the World
11:39AM  Bristol-Myers: A Lot Not to Like at Barrons.com
09:28AM  As the Trump Rally Resumes, Buy This Battered Health Sector Blue-Chip
Jan-25-17 07:55PM  Follow the money sell health-care stocks and buy dividend shares at MarketWatch
01:35PM  Bristol-Myers Squibbs 2017 Depends on This Portfolio
08:35AM  The five trades that most everybody has gotten wrong at CNBC
07:37AM  Can Amgens Romosozumab Strengthen Its Bone Health in 2017?
07:36AM  How Did 4Q16 Treat Bristol-Myers Squibbs Virology Segment?
Jan-24-17 09:51PM  What Does Trumpcare Mean For Healthcare Stocks? at Forbes
04:32PM  S&P 500, Nasdaq notch new records as Dow moves closer to 20,000 at MarketWatch
03:00PM  Grilled by Democrats on health care plans, HHS Secretary nominee Tom Price reveals nothing at MarketWatch
02:52PM  Uncertainty on drug prices a challenge for the sector: Pr...
11:48AM  Stocks advance, as Trump green-lights controversial oil pipelines
11:40AM  How Should Investors Play Healthcare? at Barrons.com
10:52AM  3 ETFs to Buy If You're Impressed With Johnson & Johnson's Fourth Quarter
10:23AM  Health care sector ETF falls for sixth-straight day, longest such streak in 16 months at MarketWatch
07:37AM  Celgene to Target Unmet Demand in Myeloid Disease Segment
07:36AM  What Do Analysts Recommend for Johnson & Johnson?
07:31AM  Why health-care stocks arent moving after President Trumps Obamacare executive order at MarketWatch
Jan-23-17 11:01AM  Can Q4 Earnings Revitalize Healthcare ETFs?
Jan-20-17 01:42PM  Dissecting the 'Trump trade' for 2017
10:27AM  Why Are Investors Flocking to Safer Bonds?
Jan-18-17 04:55PM  Quest Diagnostics CEO reveals the best and worst things about Obamacare
11:28AM  Davos WEF: Honeywell's David Cote and Quest Diagnostic's Steve Rusckowski
07:37AM  UnitedHealths OptumHealth: Will It See Strong Revenue Growth?
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at Barrons.com
09:09AM  Sector Scorecard: Technology ETF Sets All-Time High on S&P
Jan-13-17 12:19PM  Farr: Have to look at stocks on a stock-by-stock basis
12:12PM  Farr: Washington's messy, and there's room to disappoint ...
10:38AM  Behind Johnson & Johnsons Recent Stock Performance
Jan-12-17 04:31PM  Joe Tigay's Health Care SPDR ETF Options Trade
12:26PM  Eli Lilly's stock rallies after appeals court upholds favorable patent ruling at MarketWatch
07:08AM  Trump Tries Recent Enthusiasm For Healthcare ETFs
Jan-11-17 02:05PM  What Does the December Jobs Report Mean for the Economy?
01:58PM  Stocks under pressure as Trump targets drugmakers
01:41PM  Healthcare Slammed As Trump Vows To Fight Drug Prices at Investopedia
01:39PM  Trump says drugmakers are 'getting away with murder,' and biotech stocks plunge at CNBC
11:30AM  Biotech ETFs fall as Trump says more bidding needed on drugs at MarketWatch
08:47AM  Traders see floor in health-care fund
Jan-10-17 10:06AM  Illumina's stock soars toward best gain in 5 years after upbeat sales outlook, product upgrade at MarketWatch
Jan-09-17 09:28AM  Technology Rules as Only S&P Sector Hitting a New High
Jan-06-17 02:05PM  Zimmer Biomet Holdings: Hows Its Recent Stock Performance?
12:27PM  The 'Super Bowl' for health care investors
10:56AM  Analysts Recommendations for Zimmer Biomet Holdings
Jan-05-17 07:35AM  How Do Wall Street Analysts View Becton Dickinson?
Jan-04-17 05:19PM  Buy health care despite Obamacare battle?
04:05PM  Which Sector Returned the Most in 2016?
10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:34AM  Stock pickers await end of rising tide market at MarketWatch
Jan-03-17 01:05PM  What Investors Should Know about the Consumer Staples Sector
11:23AM  Is the 2017 Outlook for Healthcare Optimistic?
09:06AM  The Impact of Gilead Sciences Other Products
06:54AM  Best Sector ETFs For January: Trying To Get Healthy
Dec-29-16 01:00PM  Historical Sector ETF Performance for January (XLV, XLK) at Investopedia
10:36AM  When Will the Biosimilar for Enbrel Be Available?
Dec-28-16 01:36PM  Keytruda Is Still a Strong Growth Driver for Merck
Dec-27-16 05:16AM  2017 Playbook: Health care
Dec-23-16 04:35PM  MDTs Fitbit Collaboration Set to Accelerate Diabetes Management
Dec-22-16 11:49AM  Meet This Year's Best Healthcare ETF
09:07AM  Abraxane Is Still Witnessing Robust Demand in Solid Tumor Segment
Dec-21-16 12:12PM  Chase: Health care stocks are cheap
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG Conagra Brands, Inc. daily Stock Chart
CAG [NYSE]
Conagra Brands, Inc.
IndexS&P 500 P/E39.88 EPS (ttm)1.02 Insider Own0.10% Shs Outstand438.73M Perf Week1.73%
Market Cap17.76B Forward P/E21.58 EPS next Y1.88 Insider Trans-0.75% Shs Float434.28M Perf Month4.62%
Income448.00M PEG3.09 EPS next Q0.44 Inst Own78.80% Short Float0.95% Perf Quarter10.56%
Sales10.51B P/S1.69 EPS this Y-36.90% Inst Trans0.08% Short Ratio1.35 Perf Half Y11.70%
Book/sh10.16 P/B3.98 EPS next Y10.61% ROA4.90% Target Price41.69 Perf Year26.76%
Cash/sh3.35 P/C12.08 EPS next 5Y12.90% ROE16.10% 52W Range31.44 - 40.51 Perf YTD2.88%
Dividend0.80 P/FCF28.06 EPS past 5Y-10.30% ROI7.30% 52W High-0.07% Beta0.32
Dividend %1.98% Quick Ratio1.30 Sales past 5Y-1.20% Gross Margin28.40% 52W Low28.76% ATR0.52
Employees20900 Current Ratio1.90 Sales Q/Q-11.50% Oper. Margin9.20% RSI (14)71.38 Volatility1.64% 1.22%
OptionableYes Debt/Eq0.78 EPS Q/Q45.40% Profit Margin6.00% Rel Volume0.88 Prev Close40.20
ShortableYes LT Debt/Eq0.72 EarningsMar 23 BMO Payout69.90% Avg Volume3.05M Price40.48
Recom2.20 SMA202.65% SMA504.02% SMA20010.64% Volume2,689,232 Change0.70%
Feb-15-17Initiated Deutsche Bank Buy $46
Jan-11-17Upgrade Citigroup Neutral → Buy
Dec-23-16Reiterated Credit Suisse Neutral $35 → $40
Nov-14-16Initiated UBS Neutral $36
Nov-09-16Resumed JP Morgan Overweight $55
Oct-19-16Reiterated Stifel Hold $46 → $52
Oct-14-16Upgrade RBC Capital Mkts Sector Perform → Outperform $50 → $54
Jul-01-16Reiterated RBC Capital Mkts Sector Perform $48 → $50
Apr-08-16Reiterated Jefferies Buy $50 → $52
Apr-04-16Reiterated RBC Capital Mkts Sector Perform $46 → $48
Feb-25-16Resumed Goldman Neutral $48
Feb-12-16Upgrade BofA/Merrill Neutral → Buy
Dec-16-15Initiated Jefferies Buy
Sep-25-15Reiterated Deutsche Bank Hold $38 → $43
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-22-17 01:29PM  ConAgra CEO hopes border tax can bring opportunities, but it is 'too early to tell yet' at CNBC
Feb-20-17 09:48AM  Unilever Rejects Undervalued Merger Bid from Kraft Heinz
Feb-17-17 05:22PM  CONAGRA BRANDS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
09:39AM  Campbell Soup (CPB) Tops Q2 Earnings, Keeps FY17 Guidance
Feb-16-17 09:30AM  Zacks.com featured highlights: Conagra Brands, General Motors, Texas Instruments, Monsanto and Celanese
Feb-15-17 05:31PM  Kraft Heinz profit tops estimates as costs fall
01:54PM  Conagra Could See 15% Upside In The Next 12 Months
12:43PM  Coverage initiated on ConAgra by Deutsche Bank
07:52AM  Trump's Tax Cut Plan on the Anvil: 5 ROE Stocks to Buy
Feb-14-17 02:44PM  Molson Coors (TAP) Q4 Earnings, Sales Lags Estimates
10:59AM  Top Ranked Momentum Stocks to Buy for February 14th
Feb-13-17 10:30AM  Hain Celestials: Still Not A Buy at Barrons.com
Feb-10-17 12:56PM  TreeHouse Foods (THS) Q4 Earnings & Sales Beat Estimates
Feb-09-17 07:49PM  Cramer Remix: The real winner of the Pepsi-Coke challenge at CNBC
07:10PM  After surging 12%, TreeHouse could be your next play on organic & natural food at CNBC
06:57PM  After surging 12% TreeHouse could be your next play on or...
10:23AM  TreeHouse Shares Soar on Better Than Expected 2016 Results
08:37AM  Pilgrim's Pride (PPC) Misses on Q4 Earnings and Revenues
Feb-06-17 10:43AM  Sysco (SYY) Q2 Earnings Top on Higher Margins, Sales Meet
Feb-02-17 11:02AM  Philip Morris (PM) Q4 Earnings Miss, Sales Beat Estimates
Feb-01-17 10:22AM  Tyson Foods (TSN) to Report Q1 Earnings: What Lies in Store?
Jan-29-17 12:02PM  ConAgra CEO on Trump, defining "healthy" and Reddi-wip
Jan-26-17 08:03AM  Orville Redenbacher's Fans Stock up for Football's Biggest Game PR Newswire
Jan-25-17 10:38AM  McCormick (MKC) Q4 Earnings Meet, Sales Miss Estimates
Jan-24-17 07:18AM  Altria Shares March Higher on Sherman Buyout, Bright View
Jan-23-17 05:18PM  CONAGRA BRANDS INC. Files SEC form 8-K, Other Events
11:04AM  Why Is ConAgra Foods (CAG) Down 1.5% Since the Last Earnings Report?
Jan-20-17 09:33AM  Helen of Troy (HELE) Poised to Grow in 2017: Time to Buy?
Jan-19-17 12:31PM  ETFs with exposure to Conagra Brands, Inc. : January 19, 2017
Jan-17-17 04:51PM  Pinnacle Foods (PF) Stock Could Be a Great Pick: Here's Why
03:27PM  ConAgra Brands CEO on Turnaround: Long Way to Go
03:27PM  ConAgra Brands CEO on Turnaround: Long Way to Go at Bloomberg
03:04PM  ConAgra CEO: Innovation is as important in food business as it is in anybody's business at CNBC
03:03PM  Conagra CEO Connolly: 'The Name of the Game Now is Driving Growth, Innovation'
09:02AM  Reynolds (RAI) Downgraded to Sell on Macro Headwinds
08:19AM  Conagra Brands, Inc. :CAG-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017
Jan-16-17 10:37AM  Citigroup Upgrades Conagra Brands to a Buy
09:07AM  Raymond James Upgrades Visteon Corporation to Outperform
07:37AM  Who Were the Outliers in the Consumer Space on January 12?
Jan-11-17 09:48AM  Top Ranked Income Stocks to Buy for January 11th
09:30AM  The Zacks Analyst Blog Highlights: JPMorgan, Texas Instruments, Starbucks, ConAgra and NVIDIA
08:43AM  Conagra's (CAG) Growth Initiatives Look Good: Time to Buy?
08:33AM  Brown-Forman's Growth Efforts on Track Amid Currency Woes
Jan-10-17 01:45PM  Top Research Reports for Starbucks, JPMorgan & Texas Instruments
09:28AM  [$$] Lamb Weston Tops Views in First Quarterly Report at The Wall Street Journal
Jan-09-17 09:01AM  Reddi-wip Introduces New Recipe Business Wire
Jan-07-17 01:04PM  CONAGRA BRANDS INC. Financials
Jan-05-17 09:07AM  Whats the Latest News on Hormel Foods?
Jan-04-17 09:12AM  CONAGRA BRANDS INC. Files SEC form 10-Q, Quarterly Report
08:15AM  Post Earnings Coverage as ConAgra Adjusted EPS Soared 25.6% Accesswire
08:00AM  Microwave Popcorn a Delicious Whole Grain Option for Those Seeking Sensible Snacks PR Newswire
Jan-03-17 03:15PM  Conagra or Ingredion: Which Stock Is More Appealing?
Dec-28-16 05:35PM  Hormel Foods International Names Gadsden Asia-Pacific President
07:00AM  Consumer Defensive: Cooking Up a Bit More Value at Morningstar
Dec-27-16 12:29AM  [$$] Conagra Stock Valuation May Be Full at Barrons.com
Dec-23-16 03:05PM  Understanding Cal-Maine Foods Performance in Fiscal 2Q17
01:35PM  How Did Conagra Brands Perform in 2Q17?
12:00PM  Conagra Brands' Latest Earnings Results Bode Well for Its Shares
11:40AM  The Outliers in the Consumer Space on December 22
08:51AM  ConAgra (CAG) Beats Q2 Earnings, Reaffirms FY17 Guidance
Dec-22-16 06:05PM  Edited Transcript of CAG earnings conference call or presentation 22-Dec-16 2:30pm GMT
04:42PM  Red Hat and Bed Bath & Beyond skid; Hershey edges higher
04:40PM  Where's the Reddi-wip? ConAgra lowers product profile during shortage
03:32PM  Stocks slide again as retailers and tech companies slip
02:26PM  Craving Packaged Food Stocks For 2017? RBC Serves Up 4 Buy-Rated Names
01:06PM  ETFs with exposure to Conagra Brands, Inc. : December 22, 2016
11:36AM  Conagra: Sizzling! at Barrons.com
11:28AM  ConAgra's profit beat sends shares to record high
09:31AM  CORRECTING and REPLACING Conagra Brands Announces Details of Fiscal 2017 Second Quarter Earnings Release and Conference Call Business Wire
09:15AM  Conagra Sales Light, Says on Track With Focus Change
08:58AM  [$$] ConAgra Revenue Falls As it Cuts Discounting at The Wall Street Journal
08:54AM  CONAGRA BRANDS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:07AM  ConAgra beats 2Q profit forecasts
07:54AM  ConAgra's profit beats on less discounting
07:53AM  Early movers: CAG, RAD, NKE, HSY, MU, APC & more at CNBC
07:35AM  ConAgra posts lower-than-expected quarterly sales
07:27AM  Conagra Brands Reports Continued Margin Expansion and EPS Growth in Second Quarter Business Wire
07:07AM  Q2 2017 ConAgra Foods Inc Earnings Release - 09:30 am ET
06:15AM  Stocks to Watch: December 22, 2016
Dec-21-16 05:25AM  When Billionaire Activist Barry Rosenstein Buys These Stocks, You Sell Them at Insider Monkey
Dec-20-16 05:07PM  There's a nationwide shortage of this holiday treat
08:49AM  Breakout time for ConAgra?
08:22AM  Conagra (CAG) Looks Bearish: Should You Sell the Stock?
Dec-19-16 06:01PM  Whippocalypse? U.S. ready-made whipped cream in short supply
09:06AM  J.P. Morgan Rated Pinnacle Foods as Overweight
07:37AM  McCormick & Company Acquired Enrico Giotti SpA for $127 Million
12:07AM  [$$] Processed Food Brands Look for Fresh Makeover at The Wall Street Journal
Dec-17-16 12:08PM  [$$] Processed Food Brands Look for Makeover at The Wall Street Journal
12:08PM  Processed Food Brands Look for Fresh Makeover
Dec-15-16 01:45PM  Conagra Brands Announces Details of Fiscal 2017 Second Quarter Earnings Release and Conference Call Business Wire
09:05AM  Why Did the US Department of Justice Fine ConAgra Brands?
Dec-14-16 04:41PM  Avery Dennison Announces Acquisition of Hanita Coatings
10:32AM  Tainted peanut butter leads to $11.2M penalty a decade later
10:01AM  ConAgra hit with $11.2M fine
09:31AM  TreeHouse Foods Continues to Face Headwinds: Time to Sell?
01:21AM  PRESS DIGEST- New York Times business news - Dec 14 Reuters
Dec-13-16 08:20PM  ConAgra gets largest fine ever in food safety case for poisoned Georgia peanut butter at bizjournals.com
05:37PM  [$$] ConAgra Unit Pleads Guilty in Salmonella Outbreak Case at The Wall Street Journal
05:21PM  ConAgra to pay $11.2M to settle tainted peanut butter case
04:17PM  CONAGRA BRANDS INC. Files SEC form 8-K, Change in Directors or Principal Officers
Conagra Brands, Inc., together with its subsidiaries, operates as a food company in North America. It operates through five segments: Grocery & Snacks, Refrigerated & Frozen, International, Foodservice, and Commercial. The Grocery & Snacks segment primarily provides branded, shelf-stable food products in various retail channels in the United States. The Refrigerated & Frozen segment offers branded, temperature controlled food products in various retail channels in the United States. The International segment primarily provides branded food products, in various temperature states, in retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, such as meals, entrees, prepared potatoes, sauces, and various custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The Commercial segment offers commercially branded and private label food and ingredients primarily to commercial, restaurant, foodservice, food manufacturing, and industrial customers. The company markets its products primarily under the Healthy Choice, Hunt's, Slim Jim, Reddi-wip, Alexia, Blake's, Frontera, Bertolli, P.F. Chang's, and Marie Callender's brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREGOR JOIE ADirectorJan 05Sale39.013,300128,73750,820Jan 09 05:17 PM
Biegger DavidEVP,Chief Supply Chain OfficerNov 17Option Exercise0.006,52806,528Nov 21 05:46 PM
Serrao DarrenEVP, Chief Growth OfficerSep 01Option Exercise0.003,23503,235Sep 06 06:04 PM
Wise Robert GSVP, Corporate ControllerJul 15Option Exercise36.8915,708579,46834,326Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 15Sale47.9015,708752,36618,618Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 14Option Exercise30.8917,245532,69835,863Jul 18 04:21 PM
Wise Robert GSVP, Corporate ControllerJul 14Sale48.1917,245830,97418,618Jul 18 04:21 PM
JURGENSEN WILLIAM GDirectorJul 08Option Exercise24.549,000220,860119,356Jul 08 04:51 PM
JURGENSEN WILLIAM GDirectorJul 08Sale47.884,636221,972114,720Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise24.549,000220,86089,850Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Option Exercise24.5481,1681,991,863191,922Jul 08 04:51 PM
GOLDSTONE STEVEN FDirectorJul 07Sale48.0441,4701,992,132150,452Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Sale48.104,607221,59785,243Jul 08 04:50 PM
Johri RajiveDirectorJul 06Option Exercise21.4715,000322,05051,259Jul 08 04:56 PM
Johri RajiveDirectorJul 06Sale47.5315,000712,87736,259Jul 08 04:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Option Exercise36.8936,6541,352,16655,272Jul 07 08:47 PM
Gehring JohnEVP and CFOJul 05Option Exercise34.58159,0575,499,729218,766Jul 07 08:56 PM
Gehring JohnEVP and CFOJul 05Sale48.14159,0577,657,06859,709Jul 07 08:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Sale48.1636,6541,765,27118,618Jul 07 08:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Option Exercise30.8912,992401,323118,541Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Sale46.3512,992602,179105,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Option Exercise24.7410,000247,400115,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Sale46.2510,000462,500105,549Apr 13 04:51 PM
McGough Thomas MPresident, Consumer FoodsApr 07Option Exercise26.1560,0001,569,000116,341Apr 11 04:50 PM
McGough Thomas MPresident, Consumer FoodsApr 07Sale46.0060,0002,760,00056,341Apr 11 04:50 PM
GILD Gilead Sciences Inc. daily Stock Chart
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E6.93 EPS (ttm)9.94 Insider Own0.30% Shs Outstand1.33B Perf Week1.89%
Market Cap91.28B Forward P/E8.67 EPS next Y7.94 Insider Trans-15.69% Shs Float1.30B Perf Month-2.63%
Income13.50B PEG- EPS next Q2.26 Inst Own77.10% Short Float0.98% Perf Quarter-7.17%
Sales30.39B P/S3.00 EPS this Y-16.50% Inst Trans-0.09% Short Ratio1.19 Perf Half Y-13.87%
Book/sh14.71 P/B4.68 EPS next Y-7.33% ROA25.60% Target Price81.58 Perf Year-20.29%
Cash/sh- P/C- EPS next 5Y-4.81% ROE82.90% 52W Range65.38 - 101.25 Perf YTD-3.88%
Dividend2.08 P/FCF- EPS past 5Y41.20% ROI72.40% 52W High-32.02% Beta1.17
Dividend %3.02% Quick Ratio4.00 Sales past 5Y29.40% Gross Margin86.00% 52W Low5.28% ATR1.47
Employees8000 Current Ratio4.20 Sales Q/Q-13.90% Oper. Margin58.00% RSI (14)43.31 Volatility2.05% 1.79%
OptionableYes Debt/Eq0.00 EPS Q/Q-26.50% Profit Margin44.40% Rel Volume0.94 Prev Close69.29
ShortableYes LT Debt/Eq0.00 EarningsFeb 07 AMC Payout18.30% Avg Volume10.75M Price68.83
Recom2.30 SMA20-2.00% SMA50-4.71% SMA200-10.97% Volume10,056,783 Change-0.66%
Feb-08-17Downgrade Citigroup Buy → Neutral
Nov-14-16Initiated Stifel Buy $100
Nov-08-16Initiated Mizuho Buy $88
Nov-02-16Reiterated RBC Capital Mkts Outperform $95 → $90
Oct-25-16Reiterated Jefferies Buy $93 → $95
Oct-03-16Reiterated RBC Capital Mkts Outperform $105 → $95
Sep-27-16Downgrade Leerink Partners Outperform → Mkt Perform $112 → $94
Sep-12-16Initiated Berenberg Buy $112
Sep-06-16Upgrade Jefferies Hold → Buy
Jul-29-16Downgrade Argus Buy → Hold
Jul-26-16Reiterated RBC Capital Mkts Outperform $120 → $105
Jul-26-16Downgrade Needham Buy → Hold
Jun-01-16Initiated Gabelli & Co Buy $109
Apr-29-16Reiterated UBS Buy $130 → $118
Apr-29-16Downgrade Maxim Group Buy → Hold
Mar-16-16Reiterated Leerink Partners Outperform $130 → $127
Feb-25-16Initiated Citigroup Buy $110
Feb-12-16Reiterated Maxim Group Buy $137 → $115
Feb-03-16Reiterated RBC Capital Mkts Outperform $130 → $120
Feb-03-16Reiterated Piper Jaffray Overweight $134 → $114
Feb-22-17 07:29PM  Cramer: Why Gilead could be a value trap at CNBC
06:21PM  Who Could Buy Bristol-Myers Squibb? at Motley Fool
05:27PM  Gilead Sciences Raises Dividend by Double Digits
04:31PM  Gilead, Glaxo Pitted In HIV Battle; Both Struggle Vs. Standard Drugs
03:53PM  3 Things Gilead Sciences' CEO Just Said That You'll Want to Know at Motley Fool
03:05PM  Gilead Sciences Expects to Witness an Earnings Fall in 2017
01:35PM  Gilead Sciences Expects to See a Revenue Fall in 2017
12:42PM  Biotech: What's Next For Gilead, Glaxo, and Merck HIV Treatments at Barrons.com
12:21PM  Genmab and J&J's cancer drug set for blockbuster sales this year
11:40AM  What Are Analysts Recommendations for Gilead Sciences in 2017?
11:36AM  Ontario Becomes First Province To List EPCLUSA On Public Drug Plan To Treat All Six Genotypes Of Chronic Hepatitis C Infection CNW Group
06:43AM  Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
12:45AM  [$$] Gilead Goes to the Head of the Line at The Wall Street Journal
Feb-21-17 04:48PM  Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
02:00PM  Did Gilead's new tool for speeding drug approval come at bargain-basement price? at bizjournals.com
01:04PM  [$$] Gilead Goes to the Head of the Line at The Wall Street Journal
11:03AM  Sarepta Sells Priority Review Voucher for $125M at Investopedia
10:05AM  Sarepta sells FDA review voucher for $125M, but analyst questions price at bizjournals.com
Feb-20-17 11:50AM  Gilead Sells Anti-Addiction Drug to Amygdala at Investopedia
10:00AM  Your Burning Biotech Questions Answered
09:57AM  Why Gilead Sciences Is a Buy at Motley Fool
Feb-18-17 05:41PM  Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc. at Motley Fool
08:23AM  Investors Are Betting Big Against Intercept Pharmaceuticals. Are They Wrong? at Motley Fool
Feb-17-17 08:49PM  Why President Trump Should Buy Gilead Sciences at Motley Fool
Feb-16-17 11:29AM  Gilead Receives Approval in Canada for ODEFSEY for the Treatment of HIV-1 Infection CNW Group
09:42AM  Why It's a Colossal Mistake to Sell Gilead Sciences Stock Now at Motley Fool
Feb-15-17 07:34PM  3 Stocks We're Watching in the First Quarter at Motley Fool
06:35PM  Cramer fires back at naysayers: Here's your proof that th...
06:22PM  Cramer fires back at naysayers: Here's your proof that this rally is real at CNBC
05:59PM  Proof the rally is real
04:29PM  Under the Microscope: Gilead's Recent Dividend Increase
12:38PM  Bristol-Myers: Don't Bet on a Pfizer Acquisition at Barrons.com
12:01PM  Gileads HIV Drug Reports Positive Trial Data at Investopedia
11:04AM  Gilead Sciences (GILD) Value Trap
09:44AM  Gilead Sciences: Its Game to Lose? at Barrons.com
09:30AM  9 Top Pharmaceutical Stocks to Buy for the Dividends at Kiplinger
08:47AM  Falling Earnings Estimates Signal Weakness Ahead for Gilead Sciences (GILD)
08:23AM  4 Stocks to Buy Near 52-Week Lows at Motley Fool
Feb-14-17 07:00PM  Gilead Announces 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve Adults Business Wire
04:32PM  ETFs with exposure to Gilead Sciences, Inc. : February 14, 2017
04:19PM  Gilead HIV Drug Tops GSK Combo, But Rivalry 'Intense' With GSK Doublet
04:18PM  Gilead (GILD) Announces Data on Combination Therapy for HIV
03:33PM  Bristol-Myers Squibb: Takeover Target? at Barrons.com
12:53PM  Why I Just Bought More Shares of Gilead Sciences, Inc. at Motley Fool
11:17AM  Gilead Sciences: Not Out of the Woods Yet? at Barrons.com
10:39AM  Consider Gilead Sciences
10:19AM  No Bottoming Signs Yet for Gilead
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics
09:25AM  The new multibillion-dollar HIV challenge no one is talking about at CNBC
08:23AM  Gilead Has 'Good News' But is it Enough? at TheStreet
07:56AM  Early movers: HUM, AET, GM, PLKI, DISCA, GNRC, ITT & more at CNBC
03:59AM  Better Buy: Illumina or Gilead Sciences? at Motley Fool
03:47AM  Gilead challenges GSK with strong HIV drug data
Feb-13-17 08:40PM  Gilead and 'Good News' Make A Rare, Joint Appearance at HIV Conference
06:45PM  Gilead Presents New Phase 2 Data on Bictegravir, an Investigational Integrase Strand Transfer Inhibitor for the Treatment of HIV Business Wire
06:45PM  Gilead Announces Findings from New Preclinical Study Evaluating Novel Class of HIV Capsid Inhibitors Business Wire
04:25PM  Can Gilead Swivel To HIV Amid Floundering Hep C Sales, GSK Rivalry?
12:14PM  Is Gilead Sciences Getting Ready for a Massive Acquisition? at Motley Fool
11:11AM  Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
09:14AM  Forget Gilead, Buy These 5 Biotech Stocks Instead
Feb-12-17 01:32PM  Gilead Sciences, Fossil Reach 3-Year Low Prices
Feb-10-17 04:10PM  Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split
10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at Barrons.com
09:55AM  Major Biotechs Scare Off Loads of Short Sellers
06:01AM  These 5 Stocks Are Showing Red Flags in February
Feb-09-17 04:04PM  Vista Outdoor, Fossil Group Dive into Thursdays 52-Week Low Club
02:50PM  Are cures bad for business?
02:49PM  Gilead's catch-22 on Hep C cure
01:03PM  Gilead Sciences, Inc. :GILD-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017
12:58PM  Gilead to Battle GlaxoSmithKline for HIV Cure at Investopedia
11:14AM  Don't Panic: Gilead Sciences Really Isn't a Value Trap at Motley Fool
10:07AM  Gilead Slashes Sales Projection and Stock Tumbles at Investopedia
09:39AM  Gilead Sciences: Dead Money? at Barrons.com
09:30AM  Today's Research Reports on Gilead Sciences and Allergan Post Earnings Accesswire
12:10AM  [$$] Gileads Boom Fades and Bust Will Linger at The Wall Street Journal
Feb-08-17 05:45PM  Gilead tanks on weak forecast -8.61%
05:00PM  Gilead Sciences to Present at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22 Business Wire
04:55PM  Why Gilead Sciences, Zillow Group, and Parsley Energy Slumped Today at Motley Fool
04:21PM  Gilead Stock Dives To 22-Month Low As Hep C Cure Drains Total Sales
04:13PM  GILEAD SCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers
04:08PM  Gilead Sciences, Fitbit Plunge into Wednesdays 52-Week Low Club
04:05PM  Twitter Lands Buy Rating As Trump Fuels User Growth; Broadcom, Microchip Upgraded
03:50PM  5 Things Gilead Sciences' Management Said as Its Stock Slumped at Motley Fool
03:26PM  Gilead Mismanaged Its Gold Mine at Bloomberg
03:10PM  US STOCKS-S&P 500 inches up while banks drag on Dow Reuters
02:42PM  Gilead: Bad Apple in the Biotech Bunch? at Barrons.com
02:12PM  Why Gilead Sciences Stock Slumped Today at Motley Fool
01:28PM  Gilead: Where's the Bottom? at Barrons.com
01:05PM  How to Trade Gilead, Parsley Energy, Twitter and More
12:49PM  Biotech Tesaro Climbs on Takeout Reports
12:35PM  What Analysts Are Saying About Gilead Sciences After Earnings
11:50AM  GlaxoSmithKline and Gilead to face off at HIV meeting next week
11:49AM  [$$] Gilead's Boom Fades and Bust Will Linger at The Wall Street Journal
11:39AM  Gilead Hepatitis C Meltdown Raises Troubling Question: Is Curing Disease Bad for Business?
11:35AM  Wednesdays Biggest Biopharma Movers
11:33AM  Gilead cured hepatitis C. Thats become its biggest problem at MarketWatch
11:07AM  Morning Movers: Allergan Gains, Panera Climbs, Gilead Tumbles at Barrons.com
11:00AM  Gilead stock slips on soft hepatitis C sales forecast
10:40AM  Gilead Sciences Just Lost $9 Billion in Market Value -- Here's Why at Motley Fool
10:39AM  Allergan Tops Revenue Forecast -- Plus Jim Cramer's Comments
Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company's products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG KEVINChief Operating OfficerFeb 10Option Exercise0.0090802,883Feb 14 12:53 PM
MARTIN JOHN CExecutive ChairmanFeb 01Option Exercise21.5873,3331,582,1593,204,429Feb 03 05:25 PM
YOUNG KEVINChief Operating OfficerFeb 01Option Exercise0.0062002,190Feb 03 05:32 PM
MARTIN JOHN CExecutive ChairmanFeb 01Sale72.5773,3335,322,0693,131,096Feb 03 05:25 PM
MARTIN JOHN CExecutive ChairmanJan 03Option Exercise21.5873,3371,582,2463,204,433Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanJan 03Sale73.5973,3375,396,9713,131,096Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanDec 01Option Exercise16.40100,0001,639,5003,231,096Dec 05 12:54 PM
WILSON GAYLE EDirectorDec 01Option Exercise0.002,1470107,486Dec 05 07:59 PM
MARTIN JOHN CExecutive ChairmanDec 01Sale73.33100,0007,332,8703,131,096Dec 05 12:54 PM
MADIGAN JOHN WDirectorNov 18Option Exercise20.71105,0002,174,025121,761Nov 22 02:45 PM
MADIGAN JOHN WDirectorNov 18Sale74.86105,0007,860,05916,761Nov 22 02:45 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffNov 09Sale79.0010,000790,000122,964Nov 14 01:03 PM
MARTIN JOHN CExecutive ChairmanNov 01Option Exercise16.40100,0001,639,5003,231,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanNov 01Sale73.76100,0007,376,0463,131,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanOct 03Option Exercise16.40100,0001,639,5003,231,096Oct 05 12:52 PM
MARTIN JOHN CExecutive ChairmanOct 03Sale77.63100,0007,762,9613,131,096Oct 05 12:52 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffSep 22Sale81.845,000409,220132,964Sep 26 04:54 PM
MILLIGAN JOHN FPresident and CEOSep 06Option Exercise20.7470,0001,451,8001,128,963Sep 08 01:35 PM
MILLIGAN JOHN FPresident and CEOSep 06Sale77.7470,0005,442,0801,058,963Sep 08 01:35 PM
MARTIN JOHN CExecutive ChairmanSep 01Option Exercise16.40100,0001,639,5003,231,096Sep 06 02:40 PM
MARTIN JOHN CExecutive ChairmanSep 01Sale77.48100,0007,748,3633,131,096Sep 06 02:40 PM
Lofton Kevin EDirectorAug 24Sale81.973,500286,8990Aug 25 05:05 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Option Exercise39.132,00078,25564,305Aug 03 04:48 PM
MARTIN JOHN CExecutive ChairmanAug 01Option Exercise16.40100,0001,639,5004,119,727Aug 03 04:51 PM
MILLIGAN JOHN FPresident and CEOAug 01Option Exercise20.7470,0001,451,8001,128,963Aug 03 04:53 PM
MILLIGAN JOHN FPresident and CEOAug 01Sale70.9470,0004,965,5901,058,963Aug 03 04:53 PM
MARTIN JOHN CExecutive ChairmanAug 01Sale80.50100,0008,049,7854,019,727Aug 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Sale79.812,000159,62062,305Aug 03 04:48 PM
Carter Paul RutherfordEVP Commercial OpsJul 31Option Exercise0.002,500063,622Aug 02 04:43 PM
MILLIGAN JOHN FPresident and CEOJul 05Option Exercise16.40112,0001,836,2401,170,963Jul 07 02:50 PM
MILLIGAN JOHN FPresident and CEOJul 05Sale84.33112,0009,444,9211,058,963Jul 07 02:50 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise24.912,00049,81063,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Option Exercise16.40100,0001,639,5004,119,727Jul 06 01:28 PM
MARTIN JOHN CExecutive ChairmanJul 01Sale84.73100,0008,472,5234,019,727Jul 06 01:28 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale83.122,000166,25061,122Jul 06 01:26 PM
MILLIGAN JOHN FPresident and CEOJun 06Option Exercise16.40112,0001,836,2401,170,963Jun 08 06:59 PM
MILLIGAN JOHN FPresident and CEOJun 06Sale86.94112,0009,736,7791,058,963Jun 08 06:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise24.912,00049,81063,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Option Exercise16.40100,0001,639,5004,119,727Jun 03 04:51 PM
MARTIN JOHN CExecutive ChairmanJun 01Sale86.72100,0008,671,9504,019,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale87.022,000174,04061,122Jun 03 04:46 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Option Exercise33.8857,0921,934,021118,214Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Sale86.8557,0924,958,60061,122Jun 02 04:35 PM
MARTIN JOHN CExecutive ChairmanMay 02Option Exercise16.40100,0001,639,5004,119,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Option Exercise16.40112,0001,836,2401,170,963May 04 02:49 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Option Exercise39.132,00078,25563,122May 04 04:23 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Sale88.722,000177,44861,122May 04 04:23 PM
MILLIGAN JOHN FPresident and CEOMay 02Sale87.71112,0009,823,9541,058,963May 04 02:49 PM
MARTIN JOHN CExecutive ChairmanMay 02Sale87.82100,0008,781,6944,019,727May 04 02:44 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Option Exercise26.9935,874968,239177,964Apr 21 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Sale100.0140,0004,000,574137,964Apr 21 01:28 PM
MILLIGAN JOHN FPresident and CEOApr 04Option Exercise16.40112,0001,836,2401,170,963Apr 05 07:30 PM
MILLIGAN JOHN FPresident and CEOApr 04Sale94.59112,00010,593,9041,058,963Apr 05 07:30 PM
MARTIN JOHN CExecutive ChairmanApr 01Option Exercise16.40100,0001,639,5004,119,727Apr 05 07:49 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise24.912,00049,81063,122Apr 05 06:36 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale91.342,000182,68061,122Apr 05 06:36 PM
MARTIN JOHN CExecutive ChairmanApr 01Sale93.24100,0009,323,5074,019,727Apr 05 07:49 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale91.235,000456,158142,090Apr 05 07:45 PM
Alton Gregg HEVP, Corp & Med AffairsMar 14Sale90.005,000450,000147,090Mar 15 07:31 PM
MARTIN JOHN CChairman and CEOMar 01Option Exercise16.40100,0001,639,5004,119,727Mar 03 02:47 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Option Exercise16.40112,0001,836,2401,170,963Mar 03 02:54 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Option Exercise24.912,00049,81063,122Mar 03 03:10 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Sale87.902,000175,80061,122Mar 03 03:10 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Sale87.79112,0009,832,9951,058,963Mar 03 02:54 PM
MARTIN JOHN CChairman and CEOMar 01Sale88.58100,0008,857,8544,019,727Mar 03 02:47 PM
V Visa Inc. daily Stock Chart
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E41.53 EPS (ttm)2.11 Insider Own0.10% Shs Outstand2.32B Perf Week1.29%
Market Cap203.64B Forward P/E22.68 EPS next Y3.87 Insider Trans-28.58% Shs Float1.85B Perf Month7.08%
Income5.99B PEG2.58 EPS next Q0.79 Inst Own94.90% Short Float2.10% Perf Quarter8.84%
Sales15.98B P/S12.75 EPS this Y-19.60% Inst Trans0.08% Short Ratio3.88 Perf Half Y8.75%
Book/sh11.15 P/B7.87 EPS next Y16.67% ROA9.80% Target Price98.03 Perf Year22.61%
Cash/sh4.10 P/C21.39 EPS next 5Y16.10% ROE20.80% 52W Range69.06 - 88.04 Perf YTD12.75%
Dividend0.66 P/FCF49.36 EPS past 5Y9.90% ROI13.60% 52W High-0.27% Beta0.94
Dividend %0.75% Quick Ratio1.40 Sales past 5Y10.40% Gross Margin- 52W Low27.14% ATR0.97
Employees11300 Current Ratio1.40 Sales Q/Q25.10% Oper. Margin53.70% RSI (14)75.62 Volatility0.91% 1.10%
OptionableYes Debt/Eq0.63 EPS Q/Q7.40% Profit Margin37.50% Rel Volume0.84 Prev Close87.92
ShortableYes LT Debt/Eq0.54 EarningsFeb 02 AMC Payout23.00% Avg Volume10.01M Price87.80
Recom1.80 SMA203.26% SMA507.29% SMA2009.66% Volume8,383,990 Change-0.14%
Feb-15-17Initiated Loop Capital Buy $98
Feb-03-17Reiterated Stifel Buy $93 → $105
Jan-20-17Upgrade Wedbush Neutral → Outperform $77 → $96
Dec-15-16Upgrade BofA/Merrill Neutral → Buy
Dec-05-16Upgrade Guggenheim Neutral → Buy
Oct-25-16Reiterated Stifel Buy $94 → $93
Oct-25-16Reiterated RBC Capital Mkts Outperform $87 → $89
Oct-25-16Downgrade Guggenheim Buy → Neutral
Jul-22-16Reiterated Stifel Buy $86 → $91
Jun-06-16Resumed JP Morgan Overweight $88
Apr-20-16Reiterated Sun Trust Rbsn Humphrey Buy $85 → $100
Apr-15-16Initiated Compass Point Neutral $80
Feb-11-16Downgrade BofA/Merrill Buy → Neutral
Dec-17-15Initiated Sterne Agee CRT Buy
Dec-16-15Initiated UBS Buy $90
Nov-03-15Reiterated RBC Capital Mkts Outperform $82 → $91
Oct-22-15Resumed Wells Fargo Outperform
Oct-19-15Reiterated Oppenheimer Outperform $81 → $85
Aug-20-15Reiterated Barclays Overweight $80 → $85
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Feb-22-17 07:34PM  You'd be a fool to bet against the market now: Cramer
07:01PM  Cramer: Is the Market Playing 'The Price Is Wrong'?
06:31PM  Cramer spells out why you would be a fool to bet against ...
06:13PM  Cramer spells out why you would be a fool to bet against the market now at CNBC
04:04PM  4 Stocks at 52-Week Highs That Are Still Worth Buying Today at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan Chase, American Express and Visa
Feb-21-17 04:05PM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
12:58PM  Finding Edge in Visa (V) Options
09:58AM  4 Blue Chip Stocks to Ride the Stellar Dow Jones Rally
Feb-20-17 11:45AM  Better Buy: Visa Inc. vs. MasterCard at Motley Fool
Feb-19-17 07:54AM  5 Stocks With Promising, Amazon-like Growth Potential at Motley Fool
Feb-16-17 05:06PM  Consumer Financial Protection Bureau wants to help boost your credit score
01:40PM  IBM, Visa Partnering on an IoT Payment Platform at Investopedia
09:00AM  IBM and Visa Turn Automobiles, Appliances and All Other Connected Devices into Potential Points of Sale with Watson Internet of Things PR Newswire
09:00AM  IBM and Visa Turn Automobiles, Appliances and All Other Connected Devices into Potential Points of Sale with Watson Internet of Things CNW Group
08:15AM  Post Earnings Coverage as Visa Reported Robust Results: Revenue Surged 25%, Adjusted EPS Soared 23% Accesswire
12:00AM  Trump, Congress and the Push for Work Visa Reform: QuickTake Q&A at Bloomberg
Feb-15-17 11:37AM  Billionaire Ken Griffin Piles Up Shares of Visa Inc. (V), Sherwin-Williams Co (SHW), Charter Communications, Inc. (CHTR) And More at Insider Monkey
09:14AM  Coverage initiated on Visa by Loop Capital
Feb-14-17 07:58PM  Visa: Cramer's Top Takeaways
07:30PM  Cramer Remix: Your roadmap to the rules of a new stock market at CNBC
07:26PM  Cramer Remix: Your roadmap to the rules of a new stock ma...
06:54PM  Visa's CEO talks about the global push into digital comme...
06:35PM  A Tectonic Shift of a Rally: Cramer's 'Mad Money' Recap (Tuesday 2/14/17)
04:13PM  Visa Checkout Is Growing Fast -- but Is That Enough? at Motley Fool
01:54PM  Canada's SecureKey wins U.S. grant for digital identity network
Feb-13-17 04:24PM  Apple, Nike, Visa Among Dow's Top 5 Gainers So Far This Year
09:30AM  The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Visa, Boeing and Merck
Feb-11-17 11:22AM  Smooth Integration with Visa Europe Fuels Another Strong Quarter for Visa Inc at Motley Fool
Feb-10-17 05:41PM  Dow 30 Stock Roundup: Coca-Cola, Disney, Visa Beat on Earnings
Feb-08-17 04:33PM  Nasdaq ekes out gains for new record, Dow hobbled by financials at MarketWatch
01:41PM  Rep. Darrell Issa Seeks to Revamp H-1B Visa Program at Bloomberg
01:04PM  VISA INC. Financials
10:36AM  Visa Gets Strong Buy from Analysts on Performance
09:30AM  The Zacks Analyst Blog Highlights: Apple, Visa and AbbVie
09:06AM  Visa Commanding Premium Valuations on Expected Growth in 2017
07:36AM  Visas Investments for Future Growth: Asian Markets
Feb-07-17 04:05PM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
01:03PM  Biotech Executives Alarmed Over Trump Visa Crackdown at Bloomberg
10:59AM  Fidelity (FIS) Q4 Earnings Meet Estimates, Revenue Up Y/Y
10:40AM  Visas Operating Margins Are High on Lower Expenses, Synergies
09:07AM  Visas Leverage Is Stable after Europe Acquisition and Repurchases
08:57AM  Weitz Investment Looks to Visa (V), Amazon (AMZN), Others for Big Returns After Subpar 2016 at Insider Monkey
07:36AM  Visas Data Processing and Services Impacted by Fees in Europe
05:00AM  Trumps H1-B Visa Crackdown Threatens Cutting-Edge U.S. Medicine at Bloomberg
05:00AM  Trumps H-1B Visa Crackdown Threatens Cutting-Edge U.S. Medicine
Feb-06-17 05:59PM  Final Trade: CRM, V & more
05:22PM  Visa Europe Highlights Health of U.S. and International Segments
02:40PM  Travel Industry on Edge as U.S. Visa Policy Upends Flight Plans
02:36PM  Visas Transactions Helped by Cross Border, Europe, and Asia
01:30PM  Locust Wood Boosts Exposure to These Companies at Insider Monkey
01:06PM  Visa Payment Volumes Rise on International Spending in 1Q17
11:34AM  Visa Sees Organic Growth on Higher Spending, Lower Expenses
10:11AM  Here's what's behind Visa's massive Q4 win
10:10AM  Stock Market News for February 06, 2017
10:10AM  Company News for February 06, 2017
10:05AM  Jefferies Has 5 Top Growth Stocks to Buy Now That Have Solid Upside Potential 24/7 Wall St.
08:21AM  Facebook Could Stay Explosive
Feb-05-17 06:40AM  U.A.E. to Adopt System Seeking to Lure Top Foreign Talent at Bloomberg
Feb-03-17 05:25PM  Final Trade: MAT, V & more
04:01PM  Financial Giants Dominate DJIA Gains Friday
03:01PM  Visa: Everywhere Investors Want to Be? at Barrons.com
03:00PM  Market Driven Higher By Financials; Visa, Banks Jump; Amazon Drops
01:46PM  Goldman Sachs, Visa Power Dow Through 20K; Can Zillow Lead The Market?
10:47AM  Dow Retakes 20,000 As Visa, Goldman, Rally; Amazon Sinks, But Amgen Soars
10:25AM  Stocks Open Higher As Payrolls Surge, Dow Passes 20,000 Again
10:11AM  Dow Jones hits 20,000 again; Visa boosts financials Freeport, Amazon down, Intel up at bizjournals.com
10:10AM  Stock Market News for February 03, 2017
09:40AM  Visa Notches Another Quarterly Earnings Beat at Investopedia
08:01AM  Early movers: AMZN, CLX, AN, HSY, F, AMGN & more at CNBC
06:38AM  Visa (V) Tops Q1 Earnings & Revenues, Reiterates FY17 View
01:10AM  Edited Transcript of V earnings conference call or presentation 2-Feb-17 10:00pm GMT
Feb-02-17 07:12PM  [$$] Visa Benefits From European Business Addition at The Wall Street Journal
06:26PM  Visa's profit, revenue tops estimates on payment volume growth
05:53PM  Senior Square executive Brougher to resign on Friday
04:51PM  Visa Smashes Q1 Earnings, Payments Volume Growth Up 47%
04:47PM  Visa's earnings rise 7 percent, beating analysts' estimates
04:36PM  Why Visa Won Big on Q1 Earnings
04:16PM  Visa shares higher as company beats earnings estimates at MarketWatch
04:13PM  Visa's quarterly profit rises 6.6 pct
04:08PM  Visa beats on top & bottom lines
04:05PM  Visa Inc. Reports Strong Fiscal First Quarter 2017 Results Business Wire
10:34AM  Costco Wholesale: What's Not to Like? Oh Yeah, the Valuation at Barrons.com
09:38AM  5 Stocks to Watch After the Market Closes Today
07:18AM  5 Things You Must Know Before the Market Opens Thursday
07:07AM  Q1 2017 Visa Inc Earnings Release - After Market Close
Feb-01-17 04:05PM  Visa Inc. Declares Quarterly Dividend Business Wire
03:37PM  5 Stocks to Watch After the Market Closes Today
12:05PM  The Top 2 Dow Stocks Reporting on Thursday
10:22AM  Amid All the Political Chaos, Visa Is the Investment 'Trump' Card
08:34AM  Will Visa (V) Stock's Rally Continue Post Q1 Earnings?
06:08AM  Key U.S. Arab Ally Says Trumps Visa Ban Doesnt Target Muslims at Bloomberg
03:07AM  Iraq's Oil Production Unscathed For Now By Trump Travel Ban at Bloomberg
Jan-31-17 04:44PM  Premium Sellers Target Visa Ahead Of Earnings at Forbes
04:42PM  Deep Dive: H1-B Visa Fears Send Indian IT Tumbling at Bloomberg
04:19PM  Mastercard Tops On Q4 Earnings, Revenue Just Misses
10:35AM  Will Visa Beat MasterCard and Amex Earnings?
Jan-30-17 01:18PM  Payment Data Systems (PYDS) Targeting Growth in 2017
10:16AM  3 ETFs to Consider if You Like Visa's First-Quarter Results
Jan-29-17 11:49PM  Trump's Visa Order: Why the Middle East Is Worried at Bloomberg
Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank's current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 07Option Exercise23.166,680154,7098,611Feb 08 04:35 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 07Sale86.006,680574,4801,931Feb 08 04:35 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 06Option Exercise23.161,95645,3016,390Feb 08 04:35 PM
Sheedy William M.EVP CORP STRAT, M&A, GRFeb 06Option Exercise14.12125,3721,769,939365,769Feb 07 06:16 PM
Sheedy William M.EVP CORP STRAT, M&A, GRFeb 06Sale85.74125,37210,749,521240,397Feb 07 06:16 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 06Sale85.874,459382,9101,931Feb 08 04:35 PM
MCINERNEY RYANPRESIDENTNov 08Sale82.9218,5001,534,09038,321Nov 09 07:06 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Option Exercise40.05772,91230,956,4591,006,756Oct 28 08:00 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Sale82.65772,91263,883,109233,844Oct 28 08:00 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG [NYSE]
PPG Industries, Inc.
IndexS&P 500 P/E48.75 EPS (ttm)2.11 Insider Own0.38% Shs Outstand262.45M Perf Week1.62%
Market Cap26.98B Forward P/E14.94 EPS next Y6.88 Insider Trans0.00% Shs Float262.45M Perf Month2.97%
Income564.00M PEG5.77 EPS next Q1.32 Inst Own71.40% Short Float1.44% Perf Quarter8.43%
Sales14.75B P/S1.83 EPS this Y-56.90% Inst Trans-3.24% Short Ratio2.40 Perf Half Y-1.48%
Book/sh18.46 P/B5.57 EPS next Y10.43% ROA5.20% Target Price110.41 Perf Year10.09%
Cash/sh7.10 P/C14.48 EPS next 5Y8.45% ROE17.20% 52W Range88.91 - 115.17 Perf YTD8.92%
Dividend1.60 P/FCF53.01 EPS past 5Y-4.50% ROI6.50% 52W High-10.74% Beta1.40
Dividend %1.56% Quick Ratio1.20 Sales past 5Y2.30% Gross Margin45.30% 52W Low15.64% ATR1.24
Employees47000 Current Ratio1.50 Sales Q/Q-1.50% Oper. Margin5.70% RSI (14)69.73 Volatility1.02% 1.20%
OptionableYes Debt/Eq0.92 EPS Q/Q-73.10% Profit Margin5.90% Rel Volume1.24 Prev Close103.00
ShortableYes LT Debt/Eq0.78 EarningsJan 19 BMO Payout47.10% Avg Volume1.58M Price102.81
Recom2.10 SMA201.98% SMA504.88% SMA2002.18% Volume1,951,353 Change-0.18%
Jan-17-17Downgrade Susquehanna Positive → Neutral
Jan-09-17Downgrade Citigroup Buy → Neutral
Dec-13-16Downgrade RBC Capital Mkts Outperform → Sector Perform $105 → $101
Oct-25-16Downgrade Argus Buy → Hold
Oct-21-16Downgrade Goldman Buy → Neutral
Oct-11-16Reiterated RBC Capital Mkts Outperform $125 → $106
Oct-11-16Downgrade Deutsche Bank Buy → Hold $122 → $100
Jul-26-16Upgrade Seaport Global Securities Accumulate → Buy $125 → $130
Jun-23-16Upgrade Longbow Neutral → Buy
Mar-22-16Resumed Credit Suisse Outperform
Jan-22-16Reiterated Deutsche Bank Buy $110 → $105
Jan-05-16Initiated Seaport Global Securities Accumulate $115
Nov-25-15Reiterated RBC Capital Mkts Outperform $115 → $129
Oct-16-15Upgrade UBS Neutral → Buy $122
Oct-16-15Reiterated Barclays Equal Weight $120 → $115
Oct-12-15Upgrade Goldman Neutral → Buy $107 → $113
Sep-14-15Reiterated RBC Capital Mkts Outperform $126 → $115
Sep-08-15Reiterated RBC Capital Mkts Outperform $145 → $126
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Feb-22-17 01:04PM  PPG INDUSTRIES INC Financials
03:28AM  PPG Industries (PPG) Up 5% Since Earnings Report: Can It Continue?
Feb-16-17 04:29PM  PPG INDUSTRIES INC Files SEC form 10-K, Annual Report
Feb-09-17 09:47AM  PPG Industries (PPG) Gets DOE Funding to Develop Agilon
Feb-08-17 03:50PM  PPG Industries (PPG), Universal Display to Boost Production
Feb-07-17 01:12PM  PPG CEO McGarry on What Trump Policies Help or Hinder
07:37AM  The politics of paint: PPG CEO
Feb-06-17 08:00AM  PPG and Universal Display Corporation to Expand Production Capacity of UniversalPHOLED Materials to Meet Growing OLED Demand Business Wire
Feb-03-17 12:35PM  Why Are Analysts Expecting Axaltas Revenue to Rise in 4Q16?
Feb-02-17 10:12AM  PPG Completes Nearly 60 COLORFUL COMMUNITIES Projects in 2016 Business Wire
Jan-24-17 12:59PM  ETFs with exposure to PPG Industries, Inc. : January 24, 2017
Jan-23-17 10:37AM  PPG Industries and Its Analysts: Major Changes in Consensus?
09:07AM  What Happened to PPGs Industrial Coatings in 4Q16?
07:38AM  What Happened to PPGs Performance Coatings Segment in 4Q16?
07:37AM  PPG Buys Automotive Refinish Coatings Maker Futian Xinshi
Jan-20-17 06:05PM  PPG Industries 4Q16 EPS versus Street Expectations and Forex Impact
06:00PM  Cramers Exec Cut: This stock could be a triple threat un...
04:28PM  PPG Industries 4Q16 Revenue Gives a Miss Due to Strong Dollar
03:20PM  PPG INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers
11:19AM  PPG Industries, Inc. :PPG-US: Earnings Analysis: Q4, 2016 By the Numbers : January 20, 2017
08:11AM  PPG Acquires Automotive Refinish Coatings Company Futian Xinshi Business Wire
06:23AM  The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)
Jan-19-17 06:53PM  Cramer Remix: Stop worrying! The Trump inauguration sell-off is not here to stay at CNBC
05:46PM  Edited Transcript of PPG earnings conference call or presentation 19-Jan-17 7:00pm GMT
05:16PM  [$$] PPG Names New Finance Chief, Posts Higher Profit at The Wall Street Journal
02:52PM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition
10:14AM  PPG Industries (PPG) Beats on Earnings in Q4, Sales Miss
09:53AM  PPG Directors Announce Quarterly Dividend of 40 Cents Per Share Business Wire
08:57AM  PPG Appoints Morales as Senior Vice President and Chief Financial Officer; Sklarsky Announces Retirement Business Wire
08:38AM  PPG Industries (PPG) Q4 Earnings Beat, Sales Miss Estimates
07:07AM  Q4 2016 PPG Industries Inc Earnings Release - Before Market Open
07:06AM  PPG Industries beats 4Q profit forecasts
06:51AM  PPG Reports Fourth Quarter and Full-Year 2016 Financial Results Business Wire
Jan-18-17 05:50PM  The Best Big Cap Earnings Charts
10:10AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : January 18, 2017
Jan-17-17 10:09AM  How to Make Money in Chemicals Right Now
07:37AM  How Is PPG Industries Stock Trading Compared to Peers?
07:24AM  PPG Industries downgraded by Susquehanna
Jan-16-17 04:05PM  PPG Industries: Analysts Recommendations ahead of Q4 Earnings
02:35PM  Why Analysts Expect PPG Industries Q4 Adjusted Earnings to Fall
12:40PM  PPG Industries 4Q16 Revenues: Why Analysts Are Bearish
07:22AM  What Lies Ahead for PPG Industries (PPG) in Q4 Earnings?
Jan-13-17 12:28PM  PPG sees call buying before earnings
Jan-10-17 11:54AM  PPG Industries, Inc. : PPG-US: Dividend Analysis : November 10th, 2016 (record date) : By the numbers : January 10, 2017
08:00AM  PPG to Highlight Automotive Coatings at 2017 NAIAS Business Wire
Jan-09-17 11:35AM  PPG Extends Its Presence in EMEA Region with DEUTEK Acquisition
Jan-06-17 06:32AM  PPG Industries Closes Buyout of Romanian Paint Maker Deutek
06:04AM  Here's Why You Should Sell Gilead, PPG, 3 More Toxic Stocks Before It's Too Late
Jan-05-17 08:45AM  PPG Industries, Inc. breached its 50 day moving average in a Bullish Manner : PPG-US : January 5, 2017
08:11AM  PPG Completes Acquisition of Romanian Paint and Coatings Manufacturer DEUTEK Business Wire
Jan-02-17 07:37AM  Analyzing PPG Industries 2016 Dividend
Dec-30-16 05:35PM  Whats Analysts Latest on PPG Industries?
03:53PM  PPG Industries Stock Price Is Still Under Pressure Post-3Q16
08:15AM  Blog Coverage PPG Sells the Plaka Business to Knauf Accesswire
Dec-29-16 07:36AM  RPM Internationals Valuations before Its Fiscal 2Q17 Results
06:09AM  PPG Industries Selling Plaka Plasterboard Business to Knauf
Dec-28-16 03:35PM  Will RPM International Beat Its 2Q16 EPS?
08:15AM  Post Earnings Coverage as Valspar Q4 Missed Market Estimates Accesswire
Dec-27-16 11:15AM  PPG Industries, Inc. Value Analysis (NYSE:PPG) : December 27, 2016
11:14AM  PPG Industries Disposes Plaka Plasterboard Business
Dec-23-16 08:11AM  PPG Reaches Agreement with Knauf for Sale of Plaka Plasterboard Business Business Wire
07:48AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : December 23, 2016
Dec-21-16 02:09PM  PPG Completes COLOURFUL COMMUNITIES Project at Whare Koa Mangere Community House in New Zealand Business Wire
02:09PM  PPG Completes COLORFUL COMMUNITIES Project at Whare Koa Mangere Community House in New Zealand Business Wire
Dec-20-16 03:12PM  PPG to Announce Fourth Quarter and Full-Year 2016 Results Jan. 19, 2017 Business Wire
Dec-12-16 01:05PM  H.B. Fuller Initiates Restructuring Program to Fuel Growth
12:20PM  ETFs with exposure to PPG Industries, Inc. : December 12, 2016
11:17AM  How PPG Industries Aims to Save $125 Million Per Year
09:24AM  PPG Industries Declares Restructuring Actions to Lower Costs
08:22AM  Blog Coverage Paint Manufacturer PPG Embarks on a Cost-Cutting Plan, Aims to Save $125 million Annually Accesswire
Dec-09-16 02:11PM  PPG INDUSTRIES INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
08:20AM  PPG announces global restructuring at bizjournals.com
07:59AM  [$$] PPG to Restructure to Reduce Costs at The Wall Street Journal
07:00AM  PPG Industries unveils latest restructuring, targeting $125 million in annual savings at MarketWatch
06:51AM  PPG Initiates Global Restructuring, Targeting $125 Million in Annual Savings Business Wire
Dec-08-16 05:07PM  PPG Industries (PPG) Launches Durastar Ultra-Cool Coatings
01:21PM  White is about to be replaced as the most popular car color at MarketWatch
Dec-07-16 10:11AM  PPG Foundation Donates $15,000 to Chicago Urban League for Project Ready Business Wire
09:13AM  PPG Industries Inks Deal to Distribute Sauereisen Products
Dec-06-16 09:42AM  PPG Industries Primer Coatings Picked by LOT Polish Airlines
08:06AM  Why Valuations for Sherwin-Williams Are Higher Than Its Peers
Dec-05-16 10:30AM  Strong Demand for PPG's Useful Products Make It a Good Investment
Dec-02-16 11:01AM  ETFs with exposure to PPG Industries, Inc. : December 2, 2016
Dec-01-16 04:58PM  PPG Industries' Homax Launches New Tough As Tile Product
07:40AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : December 1, 2016
Nov-30-16 01:17PM  HOMAX Brand by PPG Introduces New and Improved TOUGH AS TILE Product Business Wire
Nov-29-16 10:05AM  Pension Settlement Charges Weighed Heavily on PPG Industries
04:33AM  Is PPG Industries, Inc. (PPG) A Good Stock To Buy? at Insider Monkey
Nov-28-16 01:34PM  Positives and Negatives of LyondellBasells 3Q16 Earnings
Nov-23-16 10:14AM  3 Stocks That Turned $8,000 Into $90,400 (or More) in 26 Years at Motley Fool
08:17AM  PPG Industries' (PPG) Coatings Systems Selected by Airbus
Nov-22-16 06:33AM  PPG Wraps Up Sale of Interest in PFG Fiber Glass JVs
Nov-21-16 01:11PM  PPG Completes COLORFUL COMMUNITIES Project at Academy Prep Center Business Wire
01:04PM  PPG Completed Its Stake Sale in PFG Fiberglass Joint Venture
Nov-18-16 06:04PM  What Impact Will New Notes Have on PPG Industries Earnings?
05:04PM  Is PPG Industries Getting Aggressive with Increased Debt?
02:45PM  PPG Industries Unleashes Its Leverage Power with More Debt
12:50PM  McGarry of PPG to Present at 2016 Citi Basic Materials Conference Business Wire
08:11AM  PPG Completes Sale of Its Ownership Interest in PFG Fiber Glass Joint Ventures Business Wire
Nov-14-16 02:04PM  PPG Industries Now Completely Owns PPG Univer
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. It operates in three segments: Performance Coatings, Industrial Coatings, and Glass. The Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; coatings, sealants, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. The Industrial Coatings segment provides adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The Glass segment produces flat and fiber glass for use in commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Option Exercise63.749,300592,76219,506Aug 08 03:45 PM
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Sale104.089,300967,93110,206Aug 08 03:45 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Option Exercise65.7630,4502,002,24069,044Jul 28 10:15 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Sale106.6440,9504,367,01428,094Jul 28 10:15 AM
USHER THOMAS JDirectorApr 20Option Exercise0.001,09202,092Apr 22 03:30 PM
RICHENHAGEN MARTINDirectorApr 20Option Exercise0.001,092020,576Apr 22 03:25 PM
HOOPER MICHELE JDirectorApr 20Option Exercise0.001,092015,352Apr 22 03:16 PM
Sklarsky Frank SExecutive VP & CFOFeb 29Option Exercise0.0010,000024,467Mar 02 12:40 PM
BUNCH CHARLES EExecutive Chairman of BoardFeb 26Sale98.1746,2864,543,711732,911Mar 01 04:01 PM
HON Honeywell International Inc. daily Stock Chart
HON [NYSE]
Honeywell International Inc.
IndexS&P 500 P/E20.14 EPS (ttm)6.21 Insider Own0.17% Shs Outstand762.20M Perf Week1.15%
Market Cap95.31B Forward P/E16.33 EPS next Y7.66 Insider Trans-0.75% Shs Float759.38M Perf Month6.50%
Income4.81B PEG2.90 EPS next Q1.62 Inst Own76.50% Short Float0.43% Perf Quarter11.55%
Sales39.30B P/S2.42 EPS this Y2.70% Inst Trans-0.97% Short Ratio1.00 Perf Half Y7.89%
Book/sh25.41 P/B4.92 EPS next Y8.78% ROA9.20% Target Price131.55 Perf Year22.62%
Cash/sh12.95 P/C9.65 EPS next 5Y6.94% ROE25.50% 52W Range99.62 - 125.00 Perf YTD7.93%
Dividend2.66 P/FCF38.31 EPS past 5Y21.50% ROI13.80% 52W High0.03% Beta0.95
Dividend %2.13% Quick Ratio1.10 Sales past 5Y1.50% Gross Margin30.90% 52W Low25.52% ATR1.20
Employees131000 Current Ratio1.40 Sales Q/Q0.00% Oper. Margin16.40% RSI (14)82.63 Volatility0.98% 1.00%
OptionableYes Debt/Eq0.81 EPS Q/Q-12.40% Profit Margin12.20% Rel Volume0.98 Prev Close124.71
ShortableYes LT Debt/Eq0.63 EarningsJan 27 BMO Payout38.90% Avg Volume3.27M Price125.04
Recom1.80 SMA203.72% SMA505.54% SMA2009.07% Volume3,201,035 Change0.26%
Oct-10-16Reiterated RBC Capital Mkts Outperform $138 → $133
Oct-06-16Initiated Robert W. Baird Outperform $135
Apr-25-16Reiterated Stifel Buy $127 → $129
Apr-25-16Reiterated RBC Capital Mkts Outperform $121 → $122
Apr-18-16Reiterated Barclays Overweight $107 → $122
Feb-01-16Reiterated Stifel Buy $106 → $113
Dec-17-15Reiterated Oppenheimer Outperform $117 → $120
Nov-16-15Reiterated Barclays Overweight $103 → $104
Oct-20-15Reiterated Argus Buy $115 → $118
Oct-19-15Reiterated RBC Capital Mkts Outperform $121 → $120
Jul-31-15Reiterated Barclays Overweight $120 → $118
Jul-29-15Reiterated Barclays Overweight $115 → $120
Jul-21-15Reiterated Argus Buy $115 → $118
Jul-20-15Reiterated Stifel Buy $116 → $120
Jul-20-15Reiterated RBC Capital Mkts Outperform $116 → $122
May-15-15Reiterated Cowen Outperform $112 → $116
Jan-27-15Reiterated Argus Buy $106 → $115
Jan-22-15Initiated UBS Neutral $105
Dec-16-14Reiterated Stifel Buy $109 → $112
Nov-25-14Reiterated RBC Capital Mkts Outperform $105 → $116
Feb-22-17 07:30PM  Jiangsu Sailboat Petrochemicals Company Starts Honeywell UOP Methanol-to-Olefins Unit PR Newswire
09:57AM  Enterprise Products Chooses Honeywell UOP Technology For New Petrochemical Plant in Texas PR Newswire
08:24AM  Ericcson and Intel Tie Up Over 5G, Launch 5GI2 Platform
Feb-21-17 08:18PM  Is Honeywell International on Track in 2017? at Motley Fool
12:21PM  20 highs in the CNBC IQ 100 Index
Feb-17-17 01:19PM  Honeywell To Present At Barclays Industrial Select Conference PR Newswire
12:51PM  Honeywell Launches New Products, Solutions To Increase Efficiency, Productivity Across Supply Chains PR Newswire
Feb-16-17 01:04PM  HONEYWELL INTERNATIONAL INC Financials
10:00AM  Honeywell Ignites STEM Interest Through Interactive Space Camp Experience For 320 Students PR Newswire
09:38AM  India's Jet Airways Joins Growing List Of Airlines Adopting Honeywell's Flight Efficiency Services PR Newswire
09:00AM  Honeywell Lights Way For Singapore Airport Expansion PR Newswire
Feb-15-17 11:02AM  Army Warns Congress Its Budget Behavior Will Get Soldiers Killed at Forbes
Feb-14-17 07:30PM  Honeywell Technology and Controls Selected for Largest Petrochemicals Project in China PR Newswire
08:30AM  Honeywell And Seeq Collaborate To Help Industrial Customers Become Safer, More Efficient And More Reliable PR Newswire
Feb-13-17 07:01PM  Cramer: Think Trump Is Behind This Rally? Think Again
05:00PM  Stocks stay big league with new Trump rally records for Dow, Nasdaq , S&P; all-time high close for Apple at bizjournals.com
10:00AM  Honeywell Material Helping Protect Brazil's Second Largest State Police PR Newswire
Feb-10-17 04:45PM  HONEYWELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
03:56PM  HONEYWELL INTERNATIONAL INC Files SEC form 10-K, Annual Report
03:12PM  Two Dozen Dividend Growth Superstar Stocks That Look Cheap at Forbes
09:52AM  Honeywell Sets April 24th For Annual Shareowners Meeting PR Newswire
Feb-09-17 10:08AM  Honeywell Declares Quarterly Dividend PR Newswire
08:15AM  Post Earnings Coverage as Honeywell's Adjusted EPS Surged 14%; Reaffirms FY17 Outlook Accesswire
07:38AM  Could the US Recover from Low Growth in 2017?
Feb-08-17 05:59PM  Final Trade: GE, GDX & more
10:00AM  Honeywell Names Stephen Gold As Vice President And General Manager, Connected Enterprises PR Newswire
05:00AM  Honeywell Joins Clean Sky Joint Undertaking To Advance Green Aviation Technology Across Europe PR Newswire
Feb-07-17 11:48AM  Emerson Electric: I Told You So? at Barrons.com
11:11AM  Don't Forget the 'Plain Old Industrials': More Squawk From Jim Cramer
Feb-02-17 05:05PM  GE, Boeing, Oracle form coalition to support Republican border tax Reuters
03:15PM  Defense Stock Roundup: Q4 Earnings Beat at GD, Miss at SPR; BA & LMT Clinch Big Awards
01:38PM  ETFs with exposure to Honeywell International, Inc. : February 2, 2017
11:56AM  The Gabelli Value 25 Fund Shareholder Commentary 4th Quarter
Feb-01-17 03:29PM  Honeywell International Has Lost Momentum
12:32PM  Arconic CEO Klaus Kleinfeld: 'Our View in 2017 Has Been More Cautious'
12:02PM  Industrial ETF Investors! Look at Trump, Not Soft Earnings
11:48AM  I Would Be Surprised if Honeywell's Temperature Keeps Rising
09:57AM  Pertamina Using Honeywell UOP Technology To Boost Production Of Clean Fuels In Indonesia PR Newswire
Jan-31-17 03:30PM  Honeywell Launches Bluetooth-Enabled Fixed Gas Detector For Commercial, Light Industrial Applications PR Newswire
11:33AM  [$$] BC Partners Hires Former Senior Honeywell Executive Alex Ismail at The Wall Street Journal
09:57AM  Honeywell To Provide Largest Oleflex Unit In Europe For Borealis AG PR Newswire
09:46AM  Recent Weakness In Honeywell Shares Offers Buying Opportunity
09:00AM  Honeywell Introduces Home Energy Management Software for Utilities to Enhance Grid Stability, Help Homeowners Lower Energy Bills PR Newswire
Jan-30-17 05:59PM  Final Trade: DAL, URI & more
05:00PM  What to do in a Trump slump: 6 trades
11:29AM  [$$] Honeywell Posts Declines in Organic Revenue and Profit at The Wall Street Journal
10:36AM  A Closer Look at Rockwell Automations Leverage and Liquidity
10:36AM  Why 3Ms Electronics and Energy Segment Operating Margin Jumped in 4Q16
09:57AM  AL WAHA Petrochemicals Company To Use Honeywell Connected Plant To Improve Plant Performance PR Newswire
09:39AM  Honeywell International, Inc. :HON-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017
07:37AM  Pulling Back the Curtain on ROKs Fiscal 1Q17 Operating Performance
07:37AM  These Factors Led to 3Ms Revenue Growth in Safety & Graphics in 4Q16
04:33AM  [$$] China's Jetliner Dream Built With U.S., European Parts at The Wall Street Journal
Jan-28-17 11:52AM  Honeywell CEO sees management lessons in New England Patriots
Jan-27-17 11:23PM  [$$] Honeywell Posts Declines in Organic Revenue and Profit at The Wall Street Journal
06:56PM  Honeywell CEO Sees 'Animal Spirits' Lurking Going Into 2017
06:09PM  Edited Transcript of HON earnings conference call or presentation 27-Jan-17 2:30pm GMT
02:39PM  Honeywell (HON) Posts In-Line Q4 Earnings, Reaffirms View
01:34PM  Honeywell Delivers Where It Counts at Bloomberg
10:38AM  Why Did ROK Beat Analysts Fiscal 1Q17 Revenue Estimates?
10:38AM  Why Did 3Ms Industrial Segment Revenue Rise in 4Q16?
09:30AM  Stocks to Watch: Microsoft, Alphabet, Intel, Air Products, Honeywell, Colgate at The Wall Street Journal
08:11AM  Honeywell (HON) Q4: Earnings in-Line, Revenues Miss
08:05AM  Honeywell Earnings OK, Short on Revenues
07:53AM  Defense stocks in the crosshairs: HON, GD
07:39AM  Stocks to Watch: January 27, 2017
07:36AM  Honeywell Remains Hopeful After Adjusted Q4 Earnings Meet Estimates
07:23AM  Honeywell sales fall short of estimates, reaffirms 2017 guidance at MarketWatch
07:07AM  Q4 2016 Honeywell International Inc Earnings Release - Before Market Open
06:44AM  Honeywell meets 4Q profit forecasts
06:42AM  Honeywell profit falls 13.4 pct on weak aerospace businesses
06:39AM  HONEYWELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition
06:34AM  Honeywell Profit Meets Estimates as Energy-Linked Sales Rise at Bloomberg
06:30AM  Honeywell Reports Strong Finish to 2016 PR Newswire
Jan-26-17 06:00PM  Stocks Trumps 20 percent Mexico import tax, border wall could hurt and ones he might help at bizjournals.com
05:52PM  </